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Gain-of-function (GOF) variants in K+ channels cause severe childhood epilepsies, but there are no mecha-
nisms to explain how increased K+ currents lead to network hyperexcitability. Here, we introduce a human
Na+-activated K+ (KNa) channel variant (KCNT1-Y796H) into mice and, using a multiplatform approach, find
motor cortex hyperexcitability and early-onset seizures, phenotypes strikingly similar to those of human pa-
tients. Although the variant increases KNa currents in cortical excitatory and inhibitory neurons, there is an
increase in the KNa current across subthreshold voltages only in inhibitory neurons, particularly in those
with non-fast-spiking properties, resulting in inhibitory-neuron-specific impairments in excitability and action
potential (AP) generation.We further observe evidence of synaptic rewiring, including increases in homotypic
synaptic connectivity, accompanied by network hyperexcitability and hypersynchronicity. These findings
support inhibitory-neuron-specific mechanisms in mediating the epileptogenic effects of KCNT1 channel
GOF, offering cell-type-specific currents and effects as promising targets for therapeutic intervention.
INTRODUCTION
K+ channels play essential roles in regulating the membrane
excitability of neurons, and their dysfunction causes a wide
range of neurological diseases, particularly epilepsy (Köhling
and Wolfart, 2016; Villa and Combi, 2016; Oyrer et al., 2018).
Traditionally, this mechanism has been conceptualized as loss-
of-function (LOF) variants decreasing K+ currents and leading
to neuronal hyperexcitability. Recent human gene discovery ef-
forts, however, have identified novel, neurological-disease-
associated K+ channel variants that increase peak K+ current
magnitudes when expressed in heterologous cells, suggesting
that they are gain-of-function (GOF) variants (Yang et al., 2013;
Syrbe et al., 2015; Simons et al., 2015; Millichap et al., 2017;
Du et al., 2005; Miceli et al., 2015; Lee et al., 2014). Although
these variants have been biophysically characterized, how they
function in neurons and networks to cause hyperexcitability is
unknown (Niday and Tzingounis, 2018).
Among K+ channels, variants in the gene encoding the Na+-
activated K+ (KNa) channel KCNT1 (Slack, KNa 1.1) cause a range
of epilepsies, including early infantile epileptic encephalopathies
(EIEEs) (Ohba et al., 2015), malignant migrating partial seizures of
infancy (MMPSI) (Barcia et al., 2012), and autosomal dominant
nocturnal frontal lobe epilepsy (ADNFLE) (Heron et al., 2012;
Møller et al., 2015). These variants increase peak K+ current
magnitude, potentially by increasing the cooperativity (Kim
et al., 2014), enhancing the Na+ sensitivity, increasing the open
probability, and/or shifting the voltage dependence of themutant
KCNT1 channel (Tang et al., 2016; McTague et al., 2018). The
broad-spectrum K+ channel blocker quinidine can normalize
the increased K+ currents caused by pathogenic KCNT1 variants
(McTague et al., 2018; Milligan et al., 2014) and thus has been
tried as a precision therapy to treat KCNT1-associated neurode-
velopmental disease. Although some early caseswere promising
(Bearden et al., 2014), further reports showed limited therapeutic
benefit of quinidine in KCNT1-related epilepsy (Mullen et al.,
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2018; Chong et al., 2016; Fitzgerald et al., 2019), emphasizing
that an understanding of disease mechanisms beyond channel
biophysics is necessary to advance clinical treatment.
In normal neuronal physiology, there is evidence that the KNa
current mediated by KCNT1 can activate in three distinct activity
regimes: during bursts of action potentials (APs) to reduce
neuronal excitability and control interburst timing (Schwindt
et al., 1989; Wallén et al., 2007; Kim and McCormick, 1998;
Yang et al., 2007), after a single AP to increase afterhyperpolari-
zation (AHP) and enhance bursting (Franceschetti et al., 2003;
Liu and Stan Leung, 2004), or at subthreshold voltages to modify
intrinsic neuronal excitability (Martinez-Espinosa et al., 2015; Re-
ijntjes et al., 2019; Hage and Salkoff, 2012). The effect of a
KCNT1GOF variant on neuronal physiology and network activity
would therefore depend on which of these regimes were
affected. Following this, it has been hypothesized that KCNT1
GOF variants lead to network hyperexcitability by (1) acceler-
ating AP repolarization selectively in excitatory neurons, thereby
limiting sodium channel inactivation and causing a higher AP
firing frequency; (2) reducing membrane excitability or inducing
spike frequency adaptation selectively in inhibitory neurons, re-
sulting in disinhibition; or (3) causing developmental alterations
in synaptic connectivity, thus leading to a hyperexcitable
network (Kim and Kaczmarek, 2014; Niday and Tzingounis,
2018; Milligan et al., 2014). To test these hypotheses, we gener-
ated a mouse model with a human-disease-causing GOF variant
in theKcnt1 gene and used amultiplatform approach to identify a
time point, brain region, and neuron type that demonstrated
strong functional alterations. We found that the Kcnt1 variant
selectively increases KNa currents in inhibitory neurons at sub-
threshold voltages to reduce their intrinsic excitability and alters
synaptic connectivity to promote a hyperexcitable and hyper-
synchronous network, thus providing a paradigm for how GOF
variants in K+ channels cause neurodevelopmental disease.
RESULTS
The Kcnt1-Y777H Mouse Model Exhibits Epileptic and
Behavioral Phenotypes Similar to Those of Human
Patients
The genetic variant Y796H (c.2386T >C; p.[Tyr796His]) inKCNT1
has been identified as a heterozygous mutation causing both in-
herited and de novo cases of a severe, early-onset form of ADN-
FLE (Heron et al., 2012; Mikati et al., 2015). In heterologous sys-
tems, the Y796H variant enhances the Na+ sensitivity of KCNT1
and increases the peak KNa current from 3- to 11-fold over the
WT channel (Tang et al., 2016; Milligan et al., 2014). To model
this KCNT1 GOF variant-associated intractable childhood epi-
lepsy in mice, we introduced a missense mutation (c.2329T >
C) into the endogenous Kcnt1 allele on the C57BL/6NJ (B6NJ)
strain background (Figure 1A). This mutation encodes a Y777H
(p.[Tyr777His]) alteration corresponding to Y796H that lies adja-
cent to the NAD+-binding site of KCNT1 (Figure 1B). We gener-
ated cohorts of wild-type (WT), heterozygous (Kcnt1m/+), and ho-
mozygous (Kcnt1m/m) littermates. Genetic transmission of both
alleles was normal, and no selective lethality was seen in either
mutant genotype at any age. Western blot analysis of membrane
and cytosolic protein fractions isolated from the cortices of WT,
Kcnt1m/+, and Kcnt1m/m mice detected KCNT1 only in the mem-
brane fraction from WT mice, and importantly, levels and locali-
zation of the Y777H variant were unaltered in Kcnt1m/+ and
Kcnt1m/m mice (Figure 1C). Finally, dissected brains from 10-
to 12-week-old Kcnt1m/+ and Kcnt1m/m mice appeared similar
in morphology and size to their WT littermates (Figure 1D), sug-
gesting that expression of the Kcnt1 GOF variant does not
grossly alter brain development.
Patients with KCNT1-associated ADNFLE present with
frequent, often nocturnal seizures with a variety of phenotypes,
including hypermotor, focal with tonic posturing, and secondary
generalized tonic-clonic (Gertler et al., 2018; Mikati et al., 2015;
McTague et al., 2018; Fitzgerald et al., 2019). To test for the pres-
ence of spontaneous seizures, we monitored adult mice
(R7 weeks of age) of each genotype using video electroenceph-
alography (video-EEG) recordings. Epileptiform activity was not
observed in WT (n = 3) or Kcnt1m/+ (n = 8) mice. However, 87%
(13/15) of Kcnt1m/m mice had at least one spontaneous seizure
in an average of 38 h of continuous recording (Figure 1E, black
dots). To test the impact of the Kcnt1 GOF variant on seizure ac-
tivity in a broader genetic context, we performed video-EEG on
WT, Kcnt1m/+, and Kcnt1m/m mice on a mixed background using
an FVB-based partner strain (see STAR Methods). Of the F2 and
N2 hybrid Kcnt1
m/m mice, 100% (10/10) had at least one sponta-
neous seizure in an average of 47 h of continuous recording,
whereas seizures were not observed in WT (n = 1) or Kcnt1m/+
(n = 6) mice (Figure 1E, gray and white dots). Thus, although het-
erozygous expression of the Y796H variant is sufficient to cause
Figure 1. Homozygous Kcnt1-Y777H Mice Have Frequent, Sleep-Associated, Spontaneous Seizures
(A) Sanger sequencing chromatograms show theWT (top) and Y777H (bottom) alleles obtained from direct sequencing of PCR products amplified from genomic
DNA from a WT and a Kcnt1m/m mouse.
(B) Diagram of the KCNT1 protein shows location of the Y777H residue.
(C) Western blots show KCNT1 expression in Kcnt1Y777H (WT, Kcnt1m/+, and Kcnt1m/m) P0 cortices following membrane and cytosol fractioning. The corre-
sponding lysates from the Kcnt1 mouse knockout Kcnt1del7 (WT, Kcnt1+/, and Kcnt1/) were used as a negative control.
(D) Representative image shows similar gross morphology of brains dissected from 10- to 12-week-old WT, Kcnt1m/+, and Kcnt1m/m littermate mice. Bar graph
shows that brain weight is unaltered by the Y777H variant (WT; n = 3, Kcnt1m/+; n = 4, and Kcnt1m/m; n = 3). Data are represented as mean ± SEM.
(E) Dot plot shows the combined spontaneous generalized tonic-clonic seizure (GTCS) and tonic seizure (TS) frequency in WT, Kcnt1m/+, and Kcnt1m/m mice in
three genetic backgrounds indicated by shaded dots.
(F) Scatterplot shows that seizures are more likely to occur when lights are on. Each dot represents one Kcnt1m/m mouse and is shaded to indicate sex.
(G1–G3) Representative EEG traces show seizure episodes from B6NJ Kcnt1
m/m mice, including GTCS, TS, epileptiform discharges (EDs), and post-ictal
depression (PID) episodes as noted in each panel. The traces shown are differential recordings between front left (FL), front right (FR), and back left (BL) EEG
electrodes.
See also Figure S1 and Table S1.




frequent seizures in patients, Kcnt1-Y777H heterozygous mice
did not exhibit any detectable epileptiform activity. Therefore,
we focused the remainder of our study on Kcnt1-Y777H homo-
zygous mice to understand the contribution of K+ channel GOF
to seizure disorders.
To determine whether the seizures observed in Kcnt1m/m mice
recapitulate the signature features of those in KCNT1-associ-
ated ADNFLE patients, we analyzed the relationship between
seizure activity and sleep in Kcnt1m/m mice. Strikingly, regard-
less of mouse strain or sex, the incidence of seizure episodes
was 2-fold higher when the vivarium lights were on, corre-
sponding to the sleep period of mice (Figure 1F). Moreover, we
compared the incidence of seizures in wake, NREM sleep, and
REM sleep in seven B6NJ Kcnt1m/m mice and found that 90%
(131/145) occurred during NREM sleep (Table S1). Next, we
analyzed the video-EEG of all Kcnt1m/m mice to assess their
seizure phenotypes. Two distinct seizure types were observed:
generalized tonic-clonic seizures (GTCSs), typically lasting 30–
60 s, and tonic seizures (TSs), typically lasting 1–2 s. TSs often
preceded GTCSs (Figures 1G1 and 1G2), but TSs also occurred
without further progression, sometimes as single events but
often in clusters of two or more episodes within a few seconds
of each other (Figure 1G3). Together, these data highlight mean-
ingful parallels between pathology observed in the homozygous
mouse model and the human disease caused by the KCNT1
GOF variant, including seizure frequency, brain state-associa-
tion, and phenotype.
Because KCNT1 GOF variants are also associated with intel-
lectual disability and psychiatric conditions, including anxiety
and attention-deficit hyperactive disorder, we next performed
a series of tests to assess the effects of the Y777H variant on
mouse behavior. In an open field test, Kcnt1m/m mice exhibited
a robust hyperactivity phenotype, traveling a further distance
compared to WT littermates; however, they were not different
from WT on the elevated plus maze (Figures S1A and S1B), indi-
cating hyperactivity without changes in anxiety-like behaviors.
Kcnt1m/m mice also exhibited decreased freezing behaviors in
the contextual and cued fear conditioning tests, without changes
in post-shock freezing behavior or acoustic startle responses
(Figures S1C and S1D), suggesting learning deficits un-
confounded by sensorimotor deficits. As a global indicator of
mouse well-being, we examined nest building, which is often
reduced in neurodegenerative and psychiatric murine disease
models (Jirkof, 2014). Both Kcnt1m/m females and males were
poor nest builders comparedwithWT, as assessed using a score
of nest quality and the weight of unshredded nesting material
(Figure S1E). These data suggest that, in addition to recapitu-
lating the seizure phenotypes, Kcnt1m/m mice exhibit several
behavioral phenotypes similar to those found in ADNFLE
patients.
Widefield Ca2+ Imaging Reveals Network Hyperactivity
in the Secondary Motor Cortex of Kcnt1m/m Mice
To determine which cortical regions were most strongly
impacted by the Kcnt1 variant, we next crossed Kcnt1-Y777H
mice to the Snap25-GCaMP6s line to generate Kcnt1m/m;
Snap25G6s/+ and Kcnt1+/+; Snap25G6s/+ (hereafter referred to
as Kcnt1m/m-G6s and WT-G6s) littermates. We then imaged
spontaneous neural activity across the dorsal cortices of awake,
head-fixed, behaving Kcnt1m/m-G6s andWT-G6s adult mice us-
ing a custom tandem-lens epifluorescence macroscope (Fig-
ure 2A). Both Kcnt1m/m-G6s and WT-G6s mice exhibited dy-
namic, spatially complex patterns of spontaneous cortical
activity. To quantify this activity, we performed event detection
and plotted the width versus prominence profile of all detected
events (Figure 2B). In all Kcnt1m/m-G6s mice (n = 6), there were
narrow, large-amplitude calcium events, similar in appearance
to previous reports of interictal epileptiform discharges (IEDs)
captured using the same technique (Steinmetz et al., 2017, Rossi
et al., 2017). Importantly, these events were rarely observed in
WT-G6s littermates (n = 5). Across Kcnt1m/m-G6s mice, these
events were consistently localized to the anterior medial cortex
(Figure 2C; Video S1), consistent with previous reports of IEDs
localized to the anterior medial cortex in human patients carrying
the Y796H variant (Mikati et al., 2015). Alignment of the activity
maps from Kcnt1m/m-G6smice to the Allen Mouse Common Co-
ordinate Framework (Allen Mouse Brain Connectivity Atlas,
Wang, 2020) showed that these events localized primarily to
the secondarymotor cortex region (M2; Figures 2C and S2), sug-
gesting a regional specificity to the interictal hyperexcitability in
Kcnt1m/m mice.
In Vivo Electrocorticography Shows Early-Onset
Cortical Network Hyperactivity in Kcnt1m/m Mouse Pups
KCNT1 epileptic encephalopathy is a childhood genetic disease;
therefore, we next tested for evidence of epileptiform activity in
mouse pups by performing acute, head-fixed, unanesthetized,
in vivo electrocorticography on a cohort of Kcnt1m/m (n = 8)
andWT (n = 5) mice at postnatal day 13 (P13) to P15. Of the eight
Kcnt1m/mpups, three showeddefinite seizure activity (Figure 3A),
and all eight exhibited waveforms consistent with IEDs (Fig-
ure 3C). Electrographic seizure patterns consisted of evolving
patterns of spike and wave discharges that had restricted spatial
distribution across the cortical surface (Figure 3A). These sei-
zures lasted from 10 to 280 s and stopped spontaneously in all
cases (Figure 3B). No WT pups exhibited electrographic seizure
activity. Identical offline IED detection algorithmswere applied to
Kcnt1m/m and WT pups, with all Kcnt1m/m pups demonstrating a
higher occurrence rate of IEDs (Figure 3D). These IEDs were
focally distributed over the surface of the cortex across
Kcnt1m/m pups and, similar to the results from widefield Ca2+ im-
aging, were more concentrated in anterior regions of the soma-
tomotor cortex (Figure 3E).
The Kcnt1-Y777H Variant Impairs Excitability and AP
Generation in Cortical GABAergic, but Nnot
Glutamatergic, Neurons
Video-EEG, widefield Ca2+ imaging, and in vivo electrocorticog-
raphy all demonstrated hyperexcitable cortical networks in
Kcnt1m/m mice, starting as early as the second postnatal week.
What are the origins of this hyperexcitability? KCNT1 and the
associated KNa current have several proposed roles in the regu-
lation of membrane excitability and AP generation, andKCNT1 is
broadly expressed in neurons (Bhattacharjee et al., 2002, 2005;
Rizzi et al., 2016), including multiple subtypes of glutamatergic
and GABAergic neurons from both human and mouse cortices




(Figure S3). Thus, it has been hypothesized that KCNT1 GOF en-
hances the intrinsic excitability of glutamatergic neurons, or re-
duces that of GABAergic neurons, to generate a hyperexcitable
network. To test these hypotheses, we assessed neuron-sub-
type-specific effects of KCNT1 GOF on membrane properties
and AP firing by performing whole-cell current-clamp analysis
of cultured cortical neurons during the time frame of network hy-
perexcitability onset (days in vitro 13 [DIV13] to DIV17). The re-
corded neurons were classified as glutamatergic, fast-spiking
(FS) GABAergic, or non-fast-spiking (NFS) GABAergic, based
on expression of GFP driven by theCaMKII promoter, AP param-
eters, and evoked synaptic responses (see STAR Methods).
Figure 2. Interictal Epileptiform Discharges
(IEDs) in Kcnt1m/m Mice Localize to the Sec-
ondary Motor Cortex
(A1) GCaMP6s fluorescence in the brain of a
Kcnt1m/m-G6s mouse. (A2) Illustration of the grid of
regions of interest (ROIs) used in event detection
superimposed on a portion of the GCaMP6s fluo-
rescence image. (A3) DF/F peaks with a promi-
nence greater than 15% were identified in each
ROI.
(B1) Maximum event prominence plotted as a
function of width at half-maximum for WT-G6s and
Kcnt1m/m-G6s mice. Kcnt1m/m-G6s mice generate
events (narrow, high prominence) not seen in WT-
G6s. Lines at 875 ms and 30% DF/F indicate our
criteria for classifying events as IEDs. (B2) Overlaid
DF/F traces of all IEDs in all Kcnt1m/m-G6s mice
with the mean waveform in red. The Kcnt1m/m plot
was cropped to highlight the region containing
IEDs, which obscures one large event (0.52, 2.17).
(C) To investigate the cortical localization of spike-
like events, we generated a maximum projection
across all event frames for each IED. The average
of these is shown for each Kcnt1m/m-G6s mouse,
showing consistent peak localized to the anterior
medial cortex, mostly within primary and second-
ary motor cortices. Boundaries indicate cortical
regions demarcated by aligning brains to the Allen
Common Coordinate Framework (CCF) (see STAR
Methods).
See also Figure S2 and Video S1.
First, we assessed the membrane
excitability of Kcnt1m/m glutamatergic
neurons. If the KNa current activated at
subthreshold voltages in Kcnt1m/m neu-
rons, KCNT1 GOF would be expected to
alter the resting membrane potential
(Vrest), input resistance (Rin), AP threshold,
or theminimumamount of current needed
to trigger an AP (rheobase); however,
none of these parameters were signifi-
cantly affected by the Y777H variant in
glutamatergic neurons (Table S2; Figures
4A1 and 4A2). Alternatively, it has been hy-
pothesized that the KNa current activates
in response to AP firing and that KCNT1
GOF increases the rate of AP repolariza-
tion in glutamatergic neurons, leading to an increase in AP firing
frequency. In this case, KCNT1 GOF would be expected to alter
the AP shape; however, the AP half-width, AP repolarization rate,
and AHP were also not significantly affected by the Y777H
variant (Table S2; Figure 4A3). Accordingly, the AP firing re-
sponses to incremental current injections were also indistin-
guishable between WT and Kcnt1m/m glutamatergic neurons
(Figure 4A4). Thus, despite the reported expression of KCNT1
and KNa currents in cortical glutamatergic neurons (Budelli
et al., 2009, Rizzi et al., 2016), there were no significant alter-
ations in any of the electrophysiological parameters measured
in this neuron type.




An alternative hypothesis is that KCNT1 GOF selectively re-
duces the excitability of GABAergic neurons. Although, like glu-
tamatergic neurons, the Kcnt1m/m FS neurons showed no alter-
ations in Vrest, Rin, or AP threshold, they did show an increase in
the rheobase current (Table S2; Figures 4B1 and 4B2), suggest-
ing there may be an increased KNa current near AP threshold
levels in this neuron population. Other electrophysiological pa-
rameters assessed, including AP half-width, AP repolarization
rate, and AHP, were not affected by the Y777H variant in FS neu-
rons (Table S2; Figure 4B3). However, incremental current injec-
tions showed a decrease in the number of APs per current step in
Kcnt1m/m FS neurons relative to that of WT (Figure 4B4).
In contrast to glutamatergic and FS neurons, the Kcnt1m/m
NFS neurons showed drastic alterations in membrane properties
and AP generation relative to those of WT. The Kcnt1m/m NFS
neurons showed a decrease in Rin, accompanied by a large in-
crease in the rheobase (Figures 4C1 and 4C2), whereas the Vrest
and AP threshold were unchanged (Table S2). The membrane
capacitance (Cm) was also increased in Kcnt1
m/m NFS neurons
(Table S2). There were several other alterations to the AP param-
eters in Kcnt1m/m NFS neurons, including a narrower AP half-
width, a faster AP repolarization rate, and a larger AHP (Table
S2; Figure 4C3). These data suggest there may be a larger in-
crease in the KNa current in this neuron population or that the
KNa current is increased across a wider voltage range. Impor-
tantly, incremental current injections showed a strong decrease
Figure 3. Kcnt1m/m Mice Have Epileptic Ac-
tivity In Vivo at 2 Weeks of Age
(A) Sample raw traces from electrocorticography
array demonstrate focal, evolving ictal pattern in a
head-fixed pup.
(B) Histogram of seizure duration across Kcnt1m/m
pups. Three out of eight Kcnt1m/m pups had defi-
nite seizures, and none of the five WT pups had
seizures.
(C) Sample raw traces from surface electro-
corticography array demonstrate populations of
interictal epileptiform discharges (IEDs; orange
boxes).
(D) Histogram of IED occurrence across all func-
tioning electrocorticography channels in Kcnt1m/m
(orange) and WT (blue) pups.
(E) IED occurrence rate localized anatomically
across the electrocorticography array and pooled
across pups reveals focal distribution in mutants.
Each square represents one electrocorticography
electrode. The approximate location and scale of
the arrays on the dorsal cortical surface is shown at
left. Color map is normalized across Kcnt1m/m and
WT pups.
in the number of APs per current step in
Kcnt1m/m NFS neurons relative to that of
WT (Figure 4C4). Overall, these data
demonstrate that the Y777H variant
selectively reduces the intrinsic excit-
ability of FS and, to a greater extent,
NFS GABAergic neurons, thus providing
a functional answer to the question of
how a variant that causes a decrease in excitability could lead
to the formation of a hyperexcitable network.
The Y777H Variant Left-Shifts the Voltage-Dependent
Activation of KCNT1 and Increases Subthreshold KNa
Currents Only in GABAergic Neurons
Why are GABAergic neurons more sensitive to the effects of a
variant in a gene that is widely expressed in neurons? To address
this question, we recorded KNa currents in cultured cortical neu-
rons by applying voltage steps to voltage-clamped neurons and
comparing the delayed outward current before and after the
addition of tetrodotoxin (TTX), as KCNT1 channels are thought
to be the major contributors to this current (Budelli et al., 2009;
Reijntjes et al., 2019; Cervantes et al., 2013). Consistent with
KCNT1-mediated currents recorded previously using the same
technique, we observed KNa currents in all three WT neuron
types, beginning at approximately 10 mV and increasing with
depolarization (Figures 5A1,2–5C1,2). At more negative potentials,
the TTX-sensitive current was often net inward (Figures 5A3–
5C3), likely due to the persistent Na
+ current (INaP), which has
been shown to prime KNa for activation in some neuron types
(Budelli et al., 2009; Hage and Salkoff, 2012).
The Y777H variant altered KNa currents in ways consistent with
it being a GOF variant, but the nature of the changes was unique
to each neuron type. In allKcnt1m/m neuron types, the overall KNa
current was increased, as measured by a significant effect of




Figure 4. The Kcnt1 Y777H Variant Causes a Reduction in Membrane Excitability and AP Generation in GABAergic, but Not Glutamatergic,
Cortical Neurons
(A1–C1) Representative membrane voltage traces of WT (black) and Kcnt1
m/m (colors) neurons of the indicated type in response to current injections illustrate
differences in the input resistance (Rin) and/or rheobase between WT and Kcnt1
m/m GABAergic neurons.
(A2–C2) The individual values of Rin (x axis) and rheobase (y axis) for WT (gray) and Kcnt1
m/m (colors) neurons. The mean and SEM for each group are indicated by
the bars next to the corresponding axis.
(A3–C3) Individual values and mean ± SEM for AP half-widths and AHP in WT (black and gray) and Kcnt1
m/m (colors) neurons.
(legend continued on next page)




genotype using a linear model, and all showed apparent in-
creases in current at positive potentials compared to those of
WT (Figures 5A2–5C2). However, pairwise comparisons at each
voltage step showed voltage-dependent differences in current
increases among the Kcnt1m/m neuron types. For Kcnt1m/m glu-
tamatergic neurons, significant increases in the KNa current were
only at very depolarized voltages, from +30 to +50 mV (Fig-
ure 5A2), whereas the currents at 0 mV and below were indistin-
guishable from those ofWT (Figure 5A3). Conversely, inKcnt1
m/m
FS neurons, significant increases in KNa currents only occurred
at more negative voltage steps, including 50, 40, and
10 mV (Figures 5B2 and 5B3). Kcnt1m/m NFS neurons showed
the broadest increase in KNa currents, with significant increases
at all voltage steps from 60 to +10 mV (Figures 5C2 and 5C3).
Plotting the KNa current densities (pA/pF) of NFS neurons
showed similar results (Figure S4), suggesting that the increased
Cm of Kcnt1
m/m NFS neurons does not contribute to their
increased KNa currents.
To better assess neuron-subtype-specific effects of the
Y777H variant on KCNT1 channel function, we plotted the
mean normalized conductances of WT and Kcnt1m/m neurons
as a function of voltage (activation curves). For glutamatergic
neurons, the activation curves were not different between the
two genotypes, as indicated by their similar membrane potential
at half-maximum (V50) values (WT: 16.5 ± 1.0 mV, Kcnt1
m/m:
15.8 ± 0.6 mV, p = 0.54; Figure 5A4). These data, together with
the overlapping KNa currents observed throughout the sub-
threshold voltage range in WT and Kcnt1m/m glutamatergic neu-
rons, are consistent with the unaltered membrane properties of
Kcnt1m/m glutamatergic neurons. However, for FS and NFS
GABAergic neurons, the activation curves were significantly
left-shifted by the Y777H variant, as evidenced by a 6.5-mV
(WT: 12.1 ± 1.2 mV, Kcnt1m/m: 5.6 ± 1.4 mV, p = 0.0005; Fig-
ure 5B4) and 6.3-mV (WT: 15.7 ± 0.8 mV, Kcnt1
m/m: 9.4 ±
0.8 mV, p < 0.0001; Figure 5C4) decrease in V50, respectively.
These strong GABAergic-specific left shifts in the voltage-
dependent activation of the KCNT1-Y777H channel likely
contribute to the increases in KNa currents at subthresholdmem-
brane potentials, and the increases in rheobase and decreases
in AP firing, that were observed in the FS and NFS neurons.
Glutamatergic neurons showed large increases in the KNa
current at depolarized voltages but no effects on membrane
excitability, whereas GABAergic neurons, especially NFS,
showed smaller absolute increases but large effects on mem-
brane excitability. Reasoning that the effect of the altered KNa
current on membrane excitability would depend on how
much it increased the total membrane current (Im), we plotted
Im across all voltage steps for each neuron type, WT and
Kcnt1m/m (Figures 5A5–5C5), as well as the fractional increase
in Im caused by the variant (DI/I; Figures 5A5–5C5, lower
panels). In glutamatergic neurons, the maximal DI/I was
from +20 to +50 mV, where Kcnt1m/m neurons had a 20% in-
crease compared to WT. In FS Kcnt1m/m neurons, the
maximum DI/I was 30%, which occurred from 10
to +30 mV. In NFS Kcnt1m/m neurons, the DI/I was 50%–60%
throughout the subthreshold voltages, reaching values as
high as 65% at 20 mV. These results are consistent with
the observed neuron-subtype-specific effects of the Kcnt1
GOF variant, with the smallest fractional increase in the K+ cur-
rent occurring in glutamatergic neurons and the largest in NFS
neurons; more specifically, the large increase in DI/I across
subthreshold voltages in Kcnt1m/m NFS neurons predict the
robust effects observed on membrane excitability, including
the decreased Rin, increased rheobase, and impaired AP firing.
To provide further evidence for the specificity of the KNa cur-
rent increases and their relationship to membrane excitability,
we recordedKNa currents and assessed alterations inmembrane
excitability in neurons with heterozygous expression of the
Y777H variant (Figure S5). Heterozygous expression of Y777H
increased KNa currents in the same voltage ranges as homozy-
gous expression in all three neuron types, and with current mag-
nitudes intermediate to those seen in corresponding WT and ho-
mozygous neurons, demonstrating a gene dosage effect of the
Kcnt1-Y777H variant on KNa current increases. Furthermore,
NFS neurons with heterozygous expression of Y777H showed
an intermediate increase in rheobase current compared with
those of WT and homozygous neurons, suggesting a tight rela-
tionship between the increase in KNa current at subthreshold
voltages and the deficit in AP generation in NFS neurons.
TheKcnt1-Y777HVariant IncreasesHomotypic Synaptic
Connectivity and Induces a Hyperexcitable and
Hypersynchronous Network
Our finding that KCNT1 GOF caused a selective reduction in
GABAergic neuron excitability is not mutually exclusive with
the third proposed hypothesis, which is that KCNT1 GOF vari-
ants cause network excitability because increases in K+ current
during development alter normal patterns of synaptic connec-
tions (Kim and Kaczmarek, 2014). Thus, we tested for altered
synaptic connectivity by performing paired recordings of gluta-
matergic (excitatory [E]) and GABAergic (inhibitory [I]) neurons
and alternatively stimulating each neuron at 0.1 Hz to test base-
line connection probability (Pc) and strength at the four possible
motifs (I-I, I-E, E-I, and E-E). Pc at the I-E and E-I motifs was not
altered in Kcnt1m/m networks (Figures 6B and 6C), indicating
grossly normal synaptic interactions between glutamatergic
and GABAergic neurons. However, Pc between both I-I and E-
E pairs was higher inKcnt1m/m networks than in those ofWT (Fig-
ures 6A and 6D). The amplitudes of the evoked postsynaptic cur-
rents (ePSCs) between connected neurons was not significantly
different between genotypes for any of the four connection types
(Figures 6A–6D). Thus, in addition to impairing the excitability of
GABAergic neurons, the Y777H variant increased synaptic con-
nectivity in the network in ways that should, theoretically, further
enhance excitation (increased E-E connections) and reduce inhi-
bition (increased I-I connections).
(A4–C4) Example traces and summary data showing the number of APs (mean and SEM) per current injection step in WT (black and gray) and Kcnt1
m/m (colors)
neurons. The lines in the current/AP plots are fits to a Boltzmann sigmoidal curve and were used to determine the half-max current (I50) and the frequency-current
(f-I) slope for each group. Statistical significance was tested using generalized linear mixed models.
See also Figure S3 and Table S2.
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To determine whether the increases in synaptic connectivity
were accompanied by alterations in synaptic activity, we re-
corded spontaneous postsynaptic currents (sPSCs; sponta-
neous excitatory postsynaptic currents [sEPSCs] and sponta-
neous inhibitory postsynaptic currents [sIPSCs]) onto voltage-
clamped glutamatergic and GABAergic neurons. Similar to the
increase in E-E synaptic connectivity, we observed an increase
in sEPSC frequency onto Kcnt1m/m glutamatergic neurons (Fig-
ure 6E). Interestingly, although sEPSC frequency was not altered
onto the Kcnt1m/m GABAergic neuron population as a whole, it
was increased onto those with an NFS phenotype, suggesting
there may be a compensatory increase in excitatory drive onto
Kcnt1m/m NFS neurons (Figure S6). This increased excitatory
drive may offset the effects of the decreased membrane excit-
ability of these neurons, as sIPSCs were not significantly
affected onto Kcnt1m/m glutamatergic or GABAergic neurons
(Figure 6F). Moreover, in agreement with the ePSC measure-
ments, the amplitudes and kinetics of the sPSCs were not
different between the genotypes onto either neuron group (Table
S3). Finally, to assess the net effect of altered sPSC activity onto
Kcnt1m/m neurons, we calculated the E/I ratio, taking into ac-
count the relative frequency and size of the sPSCs. E/I ratio
onto Kcnt1m/m glutamatergic neurons was significantly higher
than that ontoWT, whereas the E/I ratio ontoGABAergic neurons
was similar between the two groups (Figure 6G). Thus, the overall
balance of excitation and inhibition in in vitro Kcnt1m/m networks
is shifted toward excitation.
Finally, we tested whether in vitro networks of Kcnt1m/m neu-
rons exhibit hyperexcitable and/or hypersynchronous behavior,
effects that would be predicted downstream of the GABAergic
impairments, increased homotypic synaptic connectivity, and
altered E/I ratio. To assess these network behaviors, we made
primary cultures of cortical neurons from Kcnt1m/m and WT P0
pups and recorded spontaneous spiking activity using multi-
electrode array (MEA) analysis. We analyzed a variety of spiking
and bursting features between DIV9 and DIV27 (see STAR
Methods). Networks of Kcnt1m/m and WT neurons matured at a
similar rate, as measured by the increase in the number of active
electrodes (nAEs) per well, which reached a maximum by DIV17
(not shown), and displayed a variety of activity patterns (Fig-
ure 6H). In networks of Kcnt1m/m neurons, we observed a hyper-
excitability phenotype, characterized by an increased mean
firing rate (MFR) and an increased bursting frequency (increase
in bursts/minute and decrease in interburst interval) (Figure 6I).
We also observed an increase in synchrony at the network level,
characterized by an increased number of network bursts (Fig-
ure 6I). Together, these data suggest that KCNT1 GOF alters
intrinsic GABAergic excitability and synaptic connectivity to pro-
mote a hyperexcitable and hypersynchronous network.
Acute Cortical Slice Recordings Confirm the Reduced
Intrinsic Excitability of Kcnt1m/m NFS GABAergic
Neurons
Having identified a brain region (Figures 2 and 3) and a neuron
type (Figures 4 and 5) that were particularly sensitive to the
Kcnt1 variant, we next wanted to test whether the physiological
changes observed in cortical neuron cultures are also present in
acute slice, an experimental preparation with a more organized
network. We first performed Nissl staining of multiple, coronal
40-mm sections, each containing portions of motor cortex (Fig-
ure 7A), from P28 WT and Kcnt1m/m littermates to examine po-
tential effects of the Kcnt1GOF variant on general cortical struc-
ture and lamination. Overall, the brain structures between WT
and Kcnt1m/m mice appeared highly similar, and the cortical re-
gions in brains of Kcnt1m/m mice showed grossly normal cortical
thickness and lamination.
We next prepared acute slices containing the anterior motor
cortex from P20 to P29 WT and Kcnt1m/m mice and performed
whole-cell recordings from pyramidal neurons (Figure 7B) and
GABAergic neurons (Figure 7F) in the medial portion of the slice.
Because more superficial cortical layers are enriched for NFS
neurons (Tremblay et al., 2016; Lee et al., 2010) and have been
reported to show higher levels of KCNT1 expression (Rizzi
et al., 2016), we current-clamped neurons in layer 2/3 and in-
jected steps to elicit APs (Figures 7C and 7G). Similar to obser-
vations in cortical neuron cultures, Kcnt1m/m glutamatergic neu-
rons showed no changes in Rin or rheobase relative to those of
WT (Figure 7D). They did, however, have a more depolarized
AP threshold (Table S4), an effect that is notably opposite of
that previously reported from Kcnt1 knockout mouse models
(Martinez-Espinosa et al., 2015; Reijntjes et al., 2019). Despite
their depolarized AP threshold, Kcnt1m/m glutamatergic neurons
showed AP firing patterns similar to those of WT glutamatergic
neurons (Figure 7E).
Importantly, Kcnt1m/m NFS neurons showed a significant
reduction in Rin and large increases in rheobase (Figure 7H)
andCm (Table S4), all of whichwere changed in the samemanner
in cultured neurons, although the AP half-width and AHP were
Figure 5. The Y777H Variant Causes Cell-Type-Specific Increases in KNa Currents
(A1–C1) Representative traces in control external solution (top), 0.5 mMTTX (middle), and the difference current (bottom), which was calculated by subtracting the
membrane current response to voltage steps (80 to +50 mV) in TTX from the response in control, in WT (black) and Kcnt1m/m (colors) neurons.
(A2–C2) Summary data show the KNa current (mean ± SEM) for each voltage step in WT (black and gray) and Kcnt1
m/m (colors) neurons.
(A3–C3) Plots of the KNa current (mean ± SEM) for each voltage step from80 to 0mV inWT (black and gray) and Kcnt1m/m (colors) neurons to illustrate the values
that are too small to be seen on the graphs in A2-C2.
(A4–C4) Normalized Conductance-Voltage (G-V)plots (mean ± SEM) for WT (black and gray) and Kcnt1
m/m (colors) neurons with Boltzmann fits. Insets show the
Vm at half-maximum (V50; mean ± SEM).
(A5–C5) Plots of the total membrane current (mean and SEM) for each voltage step from60 to +50 mV in WT (black) and Kcnt1m/m (colors) neurons. Insets show
values too small to be seen on the larger graph. Shaded red areas indicate significantly higher currents in Kcnt1m/m neurons. The plots below show the fractional
increase in the total membrane current (DI/I, mean ± SEM) caused by the Y777H variant. Statistical significance for Current-Voltage (I-V) plots was tested using
generalized linear mixed models with genotype and current step as fixed effects followed by pairwise comparisons at each level.
p values < 0.05 are labeled on the plots in A2–C2 as asterisks and on the plots in A3–C3 as red numbers. p values < 0.001 are labeled on the plots in A4–C4 as three
asterisks. See also Figures S4 and S5.
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unchanged (Table S4). Moreover, incremental current injections
demonstrated significant impairments in AP generation in NFS
neurons expressing the Y777H variant (Figure 7I). Thus, the
main finding from culture, that NFS neurons are most strongly
affected by the Kcnt1-Y777H variant, was verified in acute slices
made from a brain area with demonstrated pathology.
DISCUSSION
Classic and recent human genetic studies have provided key in-
sights into the causes of neurodevelopmental disease and se-
vere epilepsies, revealing that genetic variants in ion channels,
both ligand and voltage gated, comprise approximately one-
third of known monogenic causes of seizure disorders (Noebels,
2017). Despite the fact that molecular dysfunction of these chan-
nel variants is relatively well modeled and correctable in heterol-
ogous systems, translating these findings to therapies has faced
unexpected challenges, likely due to the developmental, cellular,
and synaptic complexity of the brain. Progress in tracing the crit-
ical steps between ion channel biophysics and pathological syn-
chronization of cortical neurons thus requires precision genetic
disease models and multi-level interrogations of their effects
(Oyrer et al., 2018; Farrell et al., 2019).
To address this, we created a mouse model with a missense
mutation in a KNa channel gene orthologous to a human
missense mutation that causes an early-onset seizure disorder
(ADNFLE). Homozygous expression of this GOF variant caused
an epileptic phenotype with strong parallels to the human dis-
ease, and electrocorticography analysis showed epileptiform
activity in Kcnt1m/m mice by P14. Early childhood seizures are
a common feature of KCNT1-associated (and numerous other)
genetic epilepsies, but seizure phenotyping is rarely done at
this age in rodents, even though early phenotyping has the po-
tential to uncover seizure phenotypes not present in adults (Loz-
ovaya et al., 2014) and improve our understanding of how well
genetic models recapitulate human diseases. Likewise, wide-
field Ca2+ imaging pinpointed the M2 region as the cortical
source of IEDs. These results do not rule out the involvement
of other cortical areas in seizure generation or speak to the
strong possibility that cortical interactions with subcortical struc-
tures are critical for seizure generation. In fact, the finding that
seizures in our model are most likely to happen during NREM
sleep, coupled with the fact that ADNFLE is also caused by var-
iants in genes that encode nicotinic acetylcholine receptor sub-
units (Phillips et al., 1995; Sutor and Zolles, 2001), suggests that
thalamic input or cholinergic transmission may play a key role in
seizure generation (Klaassen et al., 2006).
The multiplatform, in vivo phenotyping of the KCNT1 GOF
mouse model focused our cellular studies on a discrete time
and place. Results from these in vitro and ex vivo studies support
amodel in which the Kcnt1-Y777H variant increases the KNa cur-
rent over different voltage ranges in the three major neuron types
of the cerebral cortex; glutamatergic, FS GABAergic, and NFS
GABAergic. In GABAergic neurons, because it occurs at sub-
threshold voltages, the KNa current increase impairs membrane
excitability and AP generation, changes that are especially
strong in the NFS neurons. The reduced excitability of
GABAergic neurons is accompanied by increases in E-E and I-I
synaptic connectivity, and together, these alterations likely
interact to promote both hyperactivity and hypersynchrony in
the cortical circuits, especially in cortical region M2, which leads
to epileptiform discharges and seizures. This model provides a
strong framework for understanding how GOF variants in
KCNT1 lead to epilepsy; however, it remains to be seen if this
model will generalize to other GOF variants in K+ channels, or
even other variants within the KCNT1 gene.
Prior to this study, two other studies were published charac-
terizing KCNT1 GOF variants, both of which are associated
with MMPSI, an earlier onset and more severe form of epilepsy
than ADNFLE. Using a knockin mouse model, Quraishi et al.
showed that heterozygous expression of the Kcnt1-R455H
variant results in spontaneous seizure activity in four out of seven
mice (Quraishi et al., 2020). However, there were no reports of
the effects of the R455H variant on KNa currents or neuronal
physiology, making it difficult to compare with mechanistic
data from our model. In the other study, homozygous expression
of the P942L variant in human induced pluripotent stem cell
(iPSC)-derived neurons increases the KNa current, but only at
voltages above +40 mV (Quraishi et al., 2019). Similar to our
data, they reported a decrease in AP width and increase in
AHP; however, in contrast to our data, the P942L variant in-
creases the peak AP firing rate in what are presumably immature
glutamatergic neurons. This discrepancy in AP generation iden-
tified downstream of the Y796H and P942L variants may be
Figure 6. Increases in Synaptic Connectivity in Kcnt1m/m Networks Contribute to Hyperexcitability and Hypersynchrony
(A–D) Evoked postsynaptic currents (PSCs) recorded from neuron pairs (glutamatergic [excitatory (E)] and GABAergic [inhibitory (I)]) by stimulating the neuron
type indicated on the left and recording the response in the neuron type indicated on the right (WT, black; Kcnt1m/m E, orange; Kcnt1m/m I, blue). Left: example
traces of evoked ePSCs. Middle: summary data (mean ± SEM) of the connection probability (Pc) between motifs. Right: individual pair values and mean ± SEM of
peak evoked PSC amplitudes of connected pairs.
(E) Individual values and mean ± SEM of the spontaneous excitatory postsynaptic current (sEPSC) or inhibitory postsynaptic current (sIPSC) frequency onto
excitatory neurons (WT, black; Kcnt1m/m, orange).
(F) Individual values and mean ± SEM of the sEPSC or sIPSC frequency onto inhibitory neurons (WT, black; Kcnt1m/m, blue).
(G) The E/I ratio onto excitatory neurons, but not inhibitory neurons, is increased. Individual values and mean ± SEM of the E/I ratios are shown.
(H) Raster plots of multi-electrode array (MEA) data showingWT andKcnt1m/m cortical network firing across the 16 electrodes of a well of a representative plate at
DIV23. The black bars indicate spikes, and the red bars indicate bursts.
(I) Graphs plotting measures of spontaneous activity as a function of DIV on MEAs of WT (gray, n = 65 wells, 5 mice) and Kcnt1m/m (orange, n = 66 wells, 5 mice)
cortical neurons. Mean firing rate (MFR) per active electrodes, number of bursts per minute, number of network bursts, and interburst interval are each shown as
themean ±SEM. Permutated p values for mature DIV17 to DIV27 neurons calculated with aMann-WhitneyU test followed by 1,000 permutations are indicated on
the graphs.
See also Figure S6 and Table S3.
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because the KCNT1 GOF mechanism is variant and/or disease
dependent. Alternatively, we also observed an increased KNa
current at suprathreshold voltages in Kcnt1m/m glutamatergic
neurons. Thus, it is possible that early effects in cortical glutama-
tergic neuron excitability have resolved by the time we per-
formed our electrophysiology on more mature glutamatergic
neurons but could contribute to our observed increase in E-E
connectivity (Figure 6A). Future mechanistic studies using
knockin mouse models of additional KCNT1 GOF variants
should help resolve these discrepancies and clarify the general-
ity of our findings.
A caveat of our mouse model is that although a heterozygous
GOF mutation in KCNT1 is sufficient to cause ADNFLE in hu-
mans, we only detected seizures in homozygous mice. Unfortu-
nately, this caveat is not unique to our model, as several at-
tempts to generate mouse models of heterozygous LOF
mutations in K+ channel genes associated with epilepsy in hu-
mans have failed to result in a seizure phenotype in the heterozy-
gous state in mice (Oyrer et al., 2018). Nevertheless, some of
these models in the homozygous state, such as Kcna1 null
mice and knockin LOF Kcnq2 and Kcnq3 mice, display seizure
phenotypes highly similar to those of human patients (Smart
et al., 1998; Glasscock et al., 2010; Singh et al., 2008) and
have been used successfully to model the human disease and
initiate therapeutic studies (Fenoglio-Simeone et al., 2009;
Roundtree et al., 2016). Similarly, the strong parallels observed
in both the behavior and seizure phenotypes between the homo-
zygous Y777Hmousemodel and the Y796H-associated disease
suggest analogous underlying mechanisms and indicate that the
homozygous Y777H mice are a valid preclinical model. More-
over, during the preparation and review of this article, we
observed seizures in two Kcnt1-Y777H heterozygous mice,
one during a widefield Ca2+ imaging experiment and the other
during a video-EEG experiment. Thus, heterozygous expression
can result in seizures in a rodent model, but apparently at amuch
lower frequency than that observed with homozygous expres-
sion, and studies are ongoing to further characterize the hetero-
zygous Kcnt1-Y777H phenotype.
A somewhat perplexing finding from our study was that the
decreased excitability of Kcnt1m/m GABAergic neurons did not
lead to decreased sIPSC frequency onto cultured cortical gluta-
matergic or GABAergic neurons; however, there are several po-
tential explanations for this inconsistency. First, the large litera-
ture on Dravet syndrome (DS), another childhood epilepsy
disorder, has demonstrated that LOFmutations in the Na+ chan-
nel gene Scn1a decrease the excitability of inhibitory neurons.
Despite this consensus, electrophysiological recordings in slices
have sometimes failed to find reductions in sIPSC frequencies
(De Stasi et al., 2016), especially when Scn1a deletion is
restricted to NFS GABAergic neurons (Rubinstein et al., 2015),
which is likely due to the fact that a large portion of NFS
GABAergic neurons target the distal dendrites of neurons, far
from where sIPSCs are measured at the soma. Moreover, in vivo
studies of DS models have not shown a decrease in GABAergic
neuron firing rates (De Stasi et al., 2016; Tran et al., 2020), even
though SCN1A loss causes a more severe phenotype in mice
than KCNT1GOF in our model. Finally, in this study, we also pro-
vided experimental evidence that sEPSC frequency onto
Kcnt1m/m NFS GABAergic neurons is increased (Figure 6H),
which likely compensates for their reduced membrane excit-
ability and normalizes sIPSC frequency. Thus, the lack of a
decrease in sIPSC frequency is not strong evidence against
the hypothesis that inhibitory neuron dysfunction due to
KCNT1 GOF contributes to epilepsy.
Kcnt1mRNA and protein expression in the CNS are thought to
be widespread and present in both glutamatergic and
GABAergic neurons, indicating that the differential effects we
found in these neuron populations are likely not due to selective
expression of KCNT1 (Figure S3). In support of this, we found
that the Y777H variant increases KNa current in all neuron types
analyzed; however, the voltage dependence of these increased
currents in each neuron type resulted in drastically different ef-
fects on neuronal physiology. In cortical glutamatergic neurons,
the KNa current was increased in the +30 to +50 mV range, but
the effects of this increase on physiology were extremely limited.
This lack of an effect may be due to the fact that in normal phys-
iology, neurons only reach these voltages (30–50mV) at the peak
of the AP and remain there for less than amillisecond, whichmay
not allow for activation of KNa, as the time constant for full activa-
tion of KCNT1 channels has been estimated at 25–60 ms (Joiner
et al., 1998; Chen et al., 2009). Moreover, the KNa current was
increased at negative potentials in both Kcnt1m/m GABAergic
neuron types, but not in Kcnt1m/m glutamatergic neurons. The
reasons for the lack of a KNa current increase at subthreshold
Figure 7. NFS GABAergic Neurons in Layer 2/3 of Acute Slices from Motor Cortex of Kcnt1m/m Mice Show a Strong Impairment in AP
Generation
(A) Representative images of 10-week-old, Nissl-stained coronal sections at three matched bregma levels from WT (left) and Kcnt1m/m (right) mice. Scale bar,
1 mm.
(B) Schematic shows the experimental approach of recording glutamatergic neurons in layer 2/3 of the motor cortex.
(C) Representative membrane voltage traces of glutamatergic WT (black) and Kcnt1m/m (orange) neurons in response to 100, +140, and +240 pA current in-
jections.
(D) Individual neuron values, mean, and SEM of the Rin and rheobase of WT and Kcnt1
m/m glutamatergic neurons.
(E) Number of APs (mean ± SEM) per current injection step in WT and Kcnt1m/m glutamatergic neurons.
(F) Schematic shows the experimental approach of recording NFS GABAergic neurons in layer 2/3 of the motor cortex.
(G) Representative membrane voltage traces of NFS GABAergic WT (black) and Kcnt1m/m (green) neurons in response to100, +100, +180, and +300 pA current
injections.
(H) Individual neuron values, mean, and SEM of the Rin and rheobase of WT and Kcnt1
m/m NFS GABAergic neurons.
(I) Number of APs (mean ± SEM) per current injection step in WT and Kcnt1m/m NFS GABAergic neurons. The lines in the current/AP plots are fits to a Boltzmann
sigmoidal curve that were used to determine the I50. Statistical significance was tested using generalized linear mixed models.
See also Table S4.




voltages in glutamatergic neurons will require further study; how-
ever, candidate mechanisms include glutamatergic-specific
expression of alternative splice forms of KCNT1, which have
been shown to have different activation kinetics, and coexpres-
sion of other channels, such as KCNT2, which can form hetero-
mers with KCNT1 and alter its biophysical properties (Chen et al.,
2009; Joiner et al., 1998), thus protecting glutamatergic neurons
from the more severe effects of KCNT1 GOF.
In GABAergic neurons, we observed the strongest effects of
the Y777H variant on KNa currents at voltages between 60
and +10mV. The role of the KNa current in neurons, at subthresh-
old voltages in particular, has been controversial, largely
because early studies suggested that the Na+ concentration
needed to activate KNa was higher than that normally found in
neurons. However, recent studies have shown that KNa can be
activated by a persistent Na+ (NaP) current present at voltages
as low as 90 mV (Hage and Salkoff, 2012). Consistent with
this subthreshold role for KCNT1, multiple studies have shown
that mouse sensory neurons lacking a KNa current, due to
Kcnt1 knockout, have no alterations in AHP or AP repolarization
but instead show decreases in AP threshold and rheobase and
increases in AP firing (Martinez-Espinosa et al., 2015; Reijntjes
et al., 2019; Lu et al., 2015). These KCNT1 LOF effects on
neuronal physiology nicely complement our GOF effects, and
taken together, these data support a central role for KCNT1-
mediated currents in regulating neuronal excitability at sub-
threshold potentials.
Among GABAergic neurons, we identified strong KCNT1 GOF
effects on the NFS subtype, which are still electrically, molecu-
larly, and morphologically diverse, with subclasses performing
distinct roles in circuit function (Markram et al., 2015). The
similar, yet more subtle, effects on the FS subtype suggest
that there is likely not one particular subclass of inhibitory neu-
rons that is uniquely affected. What cell type differences could
account for the stronger effects of KCNT1 GOF on NFS than
FS GABAergic neurons? First, as proposed for the differential ef-
fect of the variant on glutamatergic neurons, NFS and FS
GABAergic neurons may express different KCNT1 isoforms
and/or interacting channels and proteins that alter the functional
effects of the variant. Alternatively, FS neurons already show a
large K+ conductance at subthreshold voltages. This is reflected
in their low Rin, fast time constant, and high rheobase and
caused by high expression of K+ leak channels (Okaty et al.,
2009). The relatively small effect of KCNT1 GOF on FS neurons
may simply reflect the fact that adding a KCNT1-mediated K+
conductance on top of an already large K+ conductance may
have little effect.
KCNT1 and other K+ channel GOF epilepsies are typically
treatment resistant, and the use of quinidine, which inhibits
most KCNT1 GOF variant currents in heterologous neurons,
has shown limited success in treating KCNT1-related epilepsy
in humans. Here, we show that Kcnt1m/m neurons, networks,
and mice all display clear pathology at 2 weeks of age. In addi-
tion to the changes in membrane excitability, which may be
correctable by blocking KCNT1 or other ion channel currents,
we also found increases in Cm and synaptic Pc at multiple synap-
tic motifs, which likely play a role in the generation of abnormal
network activity. These structural changes would be more diffi-
cult to reverse by modulating ion channel currents, unless
perhaps the modulation occurred prior to their occurrence,
which would argue for earlier treatment with quinidine (Dilena
et al., 2018). Alternatively, if the NaP current activates the
increased KNa current and results in reduced interneuron excit-
ability, drugs that inhibit the NaP current could have the dually
useful effect of mitigating aberrant activation of the KNa current
in NFS GABAergic neurons while still providing general damp-
ening of membrane excitability in glutamatergic neurons. NaP
current inhibitors are currently available and have been used
with success in preclinical models of Na+ channel dysfunction
(Baker et al., 2018; Anderson et al., 2014). Our data suggest
that the way forward to designing optimal treatment strategies
for genetic epilepsies is a better understanding of the complex
interactions among neuron-subtype-specific membrane cur-
rents, circuit development, and synaptic connections.
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REAGENT or RESOURCE SOURCE IDENTIFIER
Antibodies
mouse monoclonal anti-KCNT1 (S3-26) Abcam Cat# ab94578; RRID:AB_10674494
goat anti-mouse IgG polyclonal, HRP-conjugated Santa Cruz Biotechnology Cat# sc-2005; RRID:AB_631736
mouse monoclonal anti-b-Actin (C4) Santa Cruz Biotechnology Cat# sc-47778 HRP; RRID:AB_2714189
Bacterial and Virus Strains
AAV-CaMKIIa-GFP, serotype 8 UNC Gene Therapy
Center – Vector Core
N/A
Chemicals, Peptides, and Recombinant Proteins
NlaIII NEB Cat# R0125S
0.5% Trypsin-EDTA GIBCO Cat# 25300-054
DMEM media supplemented with Glutamine GIBCO Cat# 10569-010
Fetal bovine serum GE Healthcare Cat# SH3008803
MITO+ Serum Extender Corning Cat# 355006
Penicillin/Streptomycin GIBCO Cat# 15140-122
Collagen I Corning Cat# 354236
Poly-D-lysine Sigma-Aldrich Cat# P6407
Papain Worthington Biochemical Cat# LS003126
Trypsin inhibitor, Ovomucoid Worthington Biochemical Cat# LS003085
Neurobasal-A medium GIBCO Cat# 10888-022
GlutaMAX GIBCO Cat# 35050-061
B27 supplement GIBCO Cat# 17504-044
Tribromoethanol Sigma-Aldrich Cat# T48402
NBQX disodium salt Tocris Cat# 1044
Bicuculine Methiodide Hello Bio Cat# HB0893
Tetrodotoxin Citrate Abcam Cat# ab120055
Poly-D-lysine Sigma-Aldrich Cat# P0899-50MG
Hibernate A solution GIBCO Cat# A1247501
Papain-for MEA protocol Worthington Biochemical Cat# LK003178
DNase I Worthington Biochemical Cat# LK003172
HEPES GIBCO Cat# 15630-080
Fetal bovine serum-for MEA protocol GIBCO Cat# 26140-079
Laminin Sigma-Aldrich Cat# L2020
Critical Commercial Assays
My Taq Bioline Cat# BIO-25041
Pierce BCA Protein Assay Kit Thermo Fisher Scientific Cat# 23225
NeuroGrid Intan Technologies Cat# RHD2000
Classic MEA 48 Axion Biosystems Cat# M768-KAP-48
Experimental Models: Cell Lines
Primary astrocyte feeder layer This paper N/A
Primary cortical neurons This paper N/A
Experimental Models: Organisms/Strains
Mouse: Kcnt1em1(Y777H)Frk This paper N/A
Mouse: C57BL/6NJ The Jackson Laboratory Cat# JAX:005304; RRID:IMSR_JAX:005304
Mouse: FVB.129P2-Pde6b+ Tyrc-ch/AntJ The Jackson Laboratory Cat# JAX:004828; RRID:IMSR_JAX:004828
(Continued on next page)






Further information and requests for resources and reagents should be directed to and will be fulfilled by the Lead Contact, Matthew
C. Weston (mcweston@uvm.edu).
Materials Availability
The Kcnt1Y777H mouse line is available from the Lead Contact, Matthew C. Weston (mcweston@uvm.edu), with a completed Mate-
rials Transfer Agreement.
Data and Code Availability
This study did not generate datasets or code.
EXPERIMENTAL MODEL AND SUBJECT DETAILS
Mice
All mice were bred, and procedures were conducted at the Jackson Laboratory, at Columbia University Irving Medical Center, or at
the University of Vermont. Each institution is fully accredited by the Association for Assessment and Accreditation of Laboratory An-
imal Care, and all protocols were approved by their respective Institutional Animal Care and Use Committees. All experiments were
performed in accordance with respective state and federal Animal Welfare Acts and the policies of the Public Health Service. The
animal protocol numbers for Columbia University were: AC-AAAU8484, AC-AAAZ8450, AC-AAAR4414, AC-AAAU8476, and AC-
AAAT6474, and the University of Vermont were: 16-001 and 19-034.
Kcnt1Y777H knockinmice (formal gene and allele symbol:Kcnt1em1(Y777H)Frk) were generated in the C57BL/6NJ (B6NJ)mouse strain
(The Jackson Laboratory, JAX: 005304) using CRISPR/Cas9 and an oligonucleotide donor sequence as part of the Jackson
Laboratory Center for Precision Genetics program (JCPG, https://www.jax.org/research-and-faculty/research-centers/
precision-genetics-center), and maintained by backcrossing heterozygous males to wild-type B6NJ females. Kcnt1Y777H
mice were genotyped using PCR amplification primers (Kcnt1 forward primer: 50-CTAGGGCTGCAAACACAACA-30; Kcnt1 reverse
Continued
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NIS Elements Software Nikon Instruments RRID:SCR_014329
Med-PC V Software Suite, 64-bit Med Associates Cat# SOF-736
SR-LAB Startle Response System Software San Diego Instruments N/A
Video Freeze Software Med Associates Cat# SOF-843; RRID:SCR_014574
Profusion EEG 5 Software Compumedics N/A
SVD code University College
London – Cortex Lab
https://github.com/cortex-lab/widefield
MATLAB MathWorks RRID:SCR_001622
pCLAMP Clampex Software (10.3 or 10.5) Molecular Devices RRID:SCR_011323
Axograph X Software Axograph Scientific RRID:SCR_014284
AxIS Software v2.4 Axion Biosystems RRID:SCR_016308
R package - meaRtools Gelfman et al., 2018 https://cran.r-project.org/web/packages/
meaRtools/
NeuroExplorer Software Nex Technologies RRID:SCR_001818
Prism 7 GraphPad RRID:SCR_002798
SPSS IBM RRID:SCR_002865




primer: 50-TCAAGCAGCAACACGATAGG-30) with standard thermocycler amplification conditions using MyTaq master mix (Bioline,
BIO-25041), and the annealing temperature set at 58C. Following amplification, a restriction cut was performed with the enzyme
NlaIII (NEB, R0125S) to distinguish mutant (127 and 44 bp products after cut) from wild-type alleles (171 bp product). For some ex-
periments, as noted in the text, male mutant mice were crossed with FVB.129P2-Pde6b+ Tyrc-ch/AntJ (The Jackson Laboratory,
JAX: 004828) dams to generate cohorts of N2 or F2 hybrid mice.
The following additional mouse lines and strains were used for these studies: Snap25-2A-GCaMP6s-D knockin (B6.Cg-
Snap25tm3.1Hze/J, The Jackson Laboratory, JAX: 025111) and C57BL/6J (The Jackson Laboratory, JAX: 000664). Mice were main-
tained in ventilated cages at controlled temperature (22–23C), humidity60%, and 12-h light: 12-h dark cycles (lights on at 7:00 AM,
off 7:00 PM). Mice had access to regular chow and water, ad libitum. For all experiments, male and female littermates were used for
each genotype. The ages of the mice for each experiment are indicated in the Method Details section.
Primary Astrocyte Feeder Layer Culture
Astrocyte feeder layers, to support the growth and maintenance of primary neurons, were generated as previously described (Bar-
rows et al., 2017). Briefly, cortices were dissected from P0-1WT C57BL/6J mice of either sex. The cortices were incubated in 0.05%
trypsin-EDTA (GIBCO, 25300-054) for 15min at 37C in a Thermomixer (Eppendorf) with gentle agitation (800 rpm). Then, the cortices
were mechanically dissociated with a 1-mL pipette tip, and the cells were plated into T-75 flasks containing filter-sterilized astrocyte
media [DMEMmedia supplemented with glutamine (GIBCO, 10569-010), 10% fetal bovine serum (FBS, GEHealthcare, SH3008803),
1X MITO+ Serum Extender (Corning, 355006), and 0.2X penicillin/streptomycin (GIBCO, 15140-122)]. After the astrocytes reached
confluency, they were washed with PBS and incubated for 5 min in 0.05% trypsin-EDTA at 37C, washed, and then resuspended in
astrocyte media. Astrocytes were added to 6-well plates containing 25-mm coverslips (Carolina Biological, 633037) precoated with
coating mixture [0.7 mg/ml collagen I (Corning, 354236) and 0.1 mg/ml poly-D-lysine (Sigma-Aldrich, P6407) in 10 mM acetic acid].
Primary Cortical Neuron Culture for Electrophysiology
For the primary neuron culture, the dorsomedial cortices fromP0-1WT andKcnt1m/mmice of either sexwere dissected in cold HBSS.
The tissue was then digested with papain (Worthington Biochemical, LS003126) for 60-75 min and treated with an ovomucoid inhib-
itor solution (Worthington Biochemical, LS003085) for 10 min, both while shaking at 800 rpm at 37C in a Thermomixer (Eppendorf).
The cells were then mechanically dissociated and counted. The dissociated cells were added at 200,000 cells/well to 6-well plates
containing astrocyte-coated coverslips in filter-sterilized NBA plus [Neurobasal-A medium (GIBCO, 10888-022) supplemented with
1X GlutaMAX (GIBCO, 35050-061), 1X B27 supplement (GIBCO, 17504-044), and 0.2X penicillin/streptomycin (GIBCO, 15140-122)].
After plating (12-24 h), approximately 43 1010 genome copies (GC) of AAV8-CaMKIIa-GFP, serotype 8 (UNC Gene Therapy Center -
Vector Core) was added to each well to fluorescently label glutamatergic neurons. Every 3-4 days, 20%–40% of the media was re-
placed with fresh NBA plus.
METHOD DETAILS
Western Blotting
For crude membrane/cytosol fractioning, P0 cortices of either sex were homogenized in the following homogenization buffer: 0.32 M
sucrose, 10 mMHEPES pH 7.4, 2 mM EDTA in H2O, containing a protease, and a phosphatase, inhibitor cocktail. The samples were
homogenized with amotor-driven homogenizer and centrifuged at 10003 g for 15min at 4C to remove the pelleted nuclear fraction.
The supernatant was further centrifuged at 16000 rpm for 20 min at 4C to yield the cytosolic fraction in the supernatant and the pel-
leted membrane fraction. The pellet was resuspended in homogenization buffer. Protein concentrations were determined with the
Pierce BCA Protein Assay Kit (Thermo Fisher Scientific, 23225) using BSA as a standard. Sample protein (10 mg) was mixed with
4X LDS Sample Buffer (NuPAGE, NP0007), and 10X Sample Reducing Agent (NuPAGE, NP0009), heated for 10 min at 70C, sepa-
rated on a 4%–12% Bis-Tris Mini Gel (NuPAGE, NP0321), and transferred to a PVDF membrane (Millipore, ISEQ00010). Nonspecific
binding was blocked for 1 h at RT with 5%BLOTTO (Bio-Rad, 1706404) in Tris-buffered saline with 0.1% Tween (TBST). Membranes
were incubated overnight at 4C with the primary antibody mouse anti-KCNT1 (1:1000, Abcam, ab94578), washed 3 3 10 min with
TBST, incubated with the secondary antibody HRP-conjugated goat anti-mouse (1:10000, Santa Cruz Biotechnology, sc-2005) in
5%BLOTTO for 1 h at RT, and washed again 33 10min with TBST. Blots were incubated for 5 min with Pierce ECLWestern Blotting
Substrate (Thermo Fisher Scientific, 32106) and developedwith a Kodak X-OMAT 2000A Processor. Blots were stripped for 15min at
RT in ReBlot Plus Strong Solution (Millipore. 2504), blocked for 30 min in 5% BLOTTO, incubated for 1 h at RT with an HRP-conju-
gated mouse anti-b-actin antibody (1:5000, Santa Cruz Biotechnology, sc-47778) in 5% BLOTTO, and developed as previously
described. b-actin was used as a loading control.
Mouse Brain Morphology and Histology
WT, Kcnt1m/+, and Kcnt1m/m littermate mice of either sex were anesthetized with 1.5%–2.5% isoflurane and oxygen at P28, or 10-
12 weeks of age, and transcardially perfused with PBS, followed by 4% paraformaldehyde in PBS (pH 7.4). Brains were dissected
and then post-fixed overnight in 4% paraformaldehyde at 4C. Next, brains from 10-12-week-old mice were washed with PBS,
weighed, and imaged to assess gross morphology. Then, all brains were cryoprotected with 30% sucrose until sectioning. To sec-




tion, brains were frozen in Tissue-Plus O.C.T. Compound (Fisher, 23-730-571) and sectioned into 40-mm coronal slices using a cryo-
stat. Brain sections were stored in a cryoprotectant solution with 30% ethylene glycol, 20% glycerol, and 50% 1X PBS until use.
Brain sections from P28mice were stained with a NeuroTrace fluorescent Nissl stain (1:50, Molecular Probes, N-21482), according
to the manufacturer’s instructions, andmounted in Fluoromount-GMountingMedium, with DAPI (Fisher, 00-4959-52). Nissl-stained,
whole coronal section images were continuously captured with a motorized stage and automatically stitched using a 4X objective on
a Nikon-A1R-ER confocal laser microscope with NIS Elements software (eight images, 10% overlap/section).
Mouse Behavioral Tasks – Open Field Exploration
Each mouse was gently placed in the center of a clear Plexiglas arena (7.313 27.313 20.32 cm, Med Associates, ENV-510) lit with
dim light (5 lux), and allowed to ambulate freely for 60 min. Infrared (IR) beams embedded along the X, Y, Z axes of the arena auto-
matically tracked distance moved, horizontal movement, vertical movement, stereotypies, and time spent in center zone. At the end
of the test, the mouse was returned to the home cage and the arena was cleaned with 70% ethanol followed by water drying.
Mouse Behavioral Tasks – Elevated Plus Maze
The elevated plus maze test was conducted as described previously (Yang et al., 2012). The elevated plus maze consisted of two
open arms (30 3 5 cm) and two closed arms (30 3 5 x 15 cm) extending from a central area (5 3 5 cm). Photo beams embedded
at arm entrances registered movements. Room illumination was approximately 5 lux. The test began by placing the subject mouse
in the center, facing a closed arm. The mouse was allowed to freely explore the maze for 5 min. Time spent in the open arms and
closed arms, the junction, and number of entries into the open arms and closed arms, were automatically scored by the MED-PC
V 64-bit software (Med Associates, SOF-736). At the end of the test, the mouse was gently removed from the maze and returned
to its home cage. The maze was cleaned with 70% ethanol and wiped dry between subjects.
Mouse Behavioral Tasks – Acoustic Startle Response
Acoustic startle responsewas tested using the SR-LABStartle Response Systemwith SR-LAB software (SanDiego Instruments, San
Diego, CA) as described previously (Yang et al., 2012). Test sessions began by placing themouse in the Plexiglas holding cylinder for
a 5-min acclimation period. For the next 8 min, mice were presented with each of six trial types across six discrete blocks of trials, for
a total of 36 trials. The intertrial interval was 10–20 s. One trial type measured the response to no stimulus (baseline movement). The
other five trial types measured startle responses to 40 ms sound bursts of 80, 90, 100, 110, or 120 dB. The six trial types were pre-
sented in pseudorandom order such that each trial type was presented once within a block of six trials. Startle amplitude was
measured every 1 ms over a 65 ms period beginning at the onset of the startle stimulus. The maximum startle amplitude over this
sampling period was taken as the dependent variable. A background noise level of 70 dB was maintained over the duration of the
test session.
Mouse Behavioral Tasks – Fear Conditioning
Training and conditioning tests were conducted in two identical chambers (Med Associates) that were calibrated to deliver identical
footshocks. Each chamber was 303 243 21 cm with a clear polycarbonate front wall, two stainless side walls, and a white opaque
back wall. The bottom of the chamber consisted of a removable grid floor with a waste pan underneath. When placed in the chamber,
the grid floor connected with a circuit board for delivery of scrambled electric shock. Each conditioning chamber was inside a sound-
attenuating environmental chamber (Med Associates). A camera mounted on the front door of the environmental chamber recorded
test sessions, which were later scored automatically using the Video Freeze software (Med Associates, SOF-843). For the training
session, each chamber was illuminated with a white house light. An olfactory cue was added by dabbing a drop of imitation almond
flavoring solution (1:100 dilution in water) on the metal tray beneath the grid floor. The mouse was placed in the test chamber and
allowed to explore freely for 2 min. A pure tone (5 kHz, 80 dB), which serves as the conditioned stimulus (CS), was played for 30
s. During the last 2 s of the tone, a footshock (0.5 mA) was delivered as the unconditioned stimulus (US). Each mouse received three
CS-US pairings, separated by 90 s intervals. After the last CS-US pairing, the mouse remained in the chamber for another 120 s,
during which freezing behavior was scored by the Video Freeze software. Themouse was then returned to its home cage. Contextual
conditioning was tested 24 h later in the same chamber, with the same illumination and olfactory cue present but without footshock.
Eachmouse was placed in the chamber for 5 min, in the absence of CS and US, during which freezing was scored, and then returned
to its home cage. Cued conditioning was conducted 48 h after training. Contextual cues were altered by covering the grid floor with a
smooth white plastic sheet, inserting a piece of black plastic sheet bent to form a vaulted ceiling, using near infrared light instead of
white light, and dabbing vanilla instead of banana odor on the floor. The session consisted of a 3 min free exploration period followed
by 3min of the identical CS tone (5 kHz, 80 dB). Freezing was scored during both 3min segments. Themousewas then returned to its
home cage, and the chamber thoroughly cleaned of odors between sessions using 70% ethanol and water.
Mouse Behavioral Tasks – Nesting
The nesting test was performed as previously described (Deacon, 2006). Briefly, mice were placed in individual cages at 6 pm, with a
piece of nestlet weighing 2.5 g. The next morning, the remaining unshredded nestlet was weighed and a nesting score between 1 (no
nest) and 5 (perfect nest) was attributed depending on nest quality.





Electrode implantation of adult (> 7 weeks of age) male and femalemice was performed surgically as recently described (Asinof et al.,
2016). Mice were anesthetized with tribromoethanol (250 mg/kg i.p., Sigma-Aldrich, T48402). Three small burr holes were drilled in
the skull (1 mm rostral to the bregma on both sides and 2 mm caudal to the bregma on the left) 2 mm lateral to the midline. One hole
was drilled over the cerebellum as a reference. Using four teflon-coated silver wires soldered onto the pins of a microconnector
(Mouser electronics, 575-501101), the wires were placed between the dura and the brain and a dental cap was then applied. The
mice were given a post-operative analgesic of carprofen (5 mg/kg subcutaneous Rimadyl injectable) and allowed a 48-h recovery
period before recordings were taken. To record EEG signals, mice were connected to commutators (Plastics One) with flexible
recording cables to allow unrestrictedmovements within the cage. Signal (200 samples/s) was acquired on aGrael II 48 EEGamplifier
(Compumedics), and the data were examined in Profusion EEG 5 software (Compumedics). Differential amplification recordingswere
recorded pairwise between all three electrodes, as well as referential, providing a montage of six channels for each mouse. Mouse
activity was captured simultaneously by video monitoring using a Sony IPELA EP550 model camera, with an infrared light to allow
recordings in the dark. We recorded continuously for 24-72 h.
For sleep analysis, we used a custom-written MATLAB program to classify wake, NREM sleep, and REM sleep, and to detect
GTCS and TS events. The program first used fast Fourier transform (FFT) to calculate the power spectrum of the EEG using a 5 s
sliding window, sequentially shifted by 2 s increments. Then it semi-automatedly classified into different brain states using the
following criteria: NREM sleep, high power at low frequencies (1-4 Hz) and low EMG activity; REM sleep, high power at theta fre-
quencies (6-9 Hz) and low EMG activity; GTCS and TS, high power at ‘‘seizure’’ frequencies (19-23 Hz); and wake, the remaining
(or default) state.We chose the 19-23Hz band to detect seizures based on its clear separation from normal brain oscillatory activities.
The classification was followed by manual inspection to further refine the scoring. Brain states prior to each GTCS/TS event were
used in Table S1.
Widefield Calcium Imaging
Male and female mice that were heterozygous for the Snap25-GCaMP6s construct (Madisen et al., 2015) (Jackson Labs Stock No:
025111) and either homozygous Y777H or WT at the Kcnt1 locus were generated. To gain optical access to the dorsal cortex, the
animal’s scalp and the underlying periosteum were removed before coating the dorsal skull with UV cure cyanoacrylate (Loctite
4305) and attaching a custom aluminum headplate to the skull. This headplate framed the glue covered skull and allowed the animal
to be secured on a 20-cm diameter Styrofoam treadwheel during imaging sessions. In one homozygous mutant mouse the dorsal
skull was removed entirely and replaced with a glass window (Labmaker, Crystal Skull) following a previously described protocol
(Kim et al., 2016). Imaging was performed using a custom tandem-lens epifluorescence macroscope built according to a design pre-
viously described (Wekselblatt et al., 2016). This macroscopewas configured for 2.1Xmagnification using a Nikon Nikkor 50mm f/1.2
lens paired with a Nikon 105mm f/1.8 lens. During all sessions, images were acquired at 40 Hz with an Andor Zyla 5.5 10-tap sCMOS
camera set to 4 3 4-pixel binning. Successive frames were illuminated with blue and green light, and the green reflectance images
were used to estimate changes in fluorescence resulting from hemodynamic factors and correct for them in GCaMP images. For blue
illumination, we used an X-Cite 120 LED (Lumen Dynamics, XT120L) with a filter set consisting of an ET470/40x excitation filter, a
T495lpxr dichroic, and an ET525/50m emission filter (Set 49002, Chroma Technology, Bellows Falls, VT). Total blue light power deliv-
ered to the implant typically ranged from 18-21mW. For green illumination, we used a 530 nm 6.8 mW Thorlabs LED (M530F2) driven
by a Thorlabs tcube (LEDD1B) coupled to a fiber optic obliquely pointed at the brain. To switch illumination sources between frames,
we relied on an Arduino Uno R3 (A000066) microcontroller operating on the Zyla ‘expose’ signal. At the beginning of each session, we
exposed a dark frame in which no illumination was used. This frame was subtracted from all illuminated frames in the session as the
first processing step. Subsequently, reflectance and GCaMP images were deinterleaved and linearly interpolated from 20 to 40 Hz.
We calculated DF/F for each pixel in the image that covered the brain, as defined by a hand-drawn mask. We estimated F for each
pixel as the average of the bottom 20th percentile of fluorescent values over the entire session. Following DF/F calculation, we sub-
tracted fractional green fluorescence (DF/Fmean) with Fmean calculated over the full session. Finally, we performed Singular Value
Decomposition (SVD) on the DF/F image stacks and reconstructed images using the first 50 singular values for all subsequent anal-
ysis. The SVD code was a modification of that provided by the Cortex Lab group at University College London. To rigidly align area
borders derived from the Allen Common Coordinate Framework v3 to each brain, we relied on the landmark-based strategy previ-
ously described (Musall et al., 2019).
Mouse Pup Electrocorticography
Eight Kcnt1m/m and five WT pups of either sex at P13-15 were used for in vivo electrophysiology. All experiments were performed in
accordance with protocols approved by IACUC at Columbia University Irving Medical Center. Pups were anesthetized using isoflur-
ane and electromyography (EMG) electrodes were placed for real-time monitoring of respiratory rate, heart rate, and muscle activity.
The animals were then given systemic and local analgesia, head-fixed, and a craniotomywasmade over the dorsal cortical surface of
one hemisphere. This craniotomywas centered over somatomotor cortex, spanning 2.5mm in themediolateral direction and 3.5mm
in the anterioposterior direction between bregma and lambda. A NeuroGrid (ultra-conformable, biocompatible surface electrocorti-
cography array, 119 electrodes, 177 mm pitch) array was placed on the surface of the dura and covered with a piece of sterile com-
pressed sponge. The pup was transferred to a temperature and humidity-controlled enclosure and allowed to recover for 30 min,




after which recording commenced. Signals were amplified, digitized continuously at 20 kHz using a head-stage directly attached to
the NeuroGrid (RHD2000, Intan Technology), and stored for offline analysis with 16-bit format. Data were analyzed using MATLAB
(MathWorks) and visualized using Neuroscope. At the completion of electrophysiological recording, pups were euthanized.
Neurophysiologic recordings were synchronized with the EMG signals to facilitate identification and elimination of any epochs with
artifacts from subsequent analysis. Ictal patterns were identified using a line length algorithm and confirmed with visual screening of
the raw data. Interictal epileptiform discharges were detected using previously employed frequency and duration features (Gelinas
et al., 2016).
Cortical Neuron Culture Electrophysiology
Whole-cell recordings were performed with patch-clamp amplifiers (MultiClamp 700B; Molecular Devices) under the control of
pClamp Clampex 10.3 or 10.5 software (Molecular Devices). Data were acquired at 20 kHz and low-pass filtered at 6 kHz. The series
resistance was compensated at 70%, and only cells with series resistances maintained at less than 15 MU were analyzed. Patch
electrodes were pulled from 1.5-mm o.d. thin-walled glass capillaries (Sutter Instruments, BF150-86-75) in five stages on a micro-
pipette puller (model P-97; Sutter Instruments). Internal solution contained the following: 136 mM K-gluconate, 17.8 mM HEPES,
1mMEGTA, 0.6mMMgCl2, 4mMATP, 0.3mMGTP, 12mMcreatine phosphate, and 50U/ml phosphocreatine kinase. Alternatively,
internal solution contained: 136 mm KCl, 17.8 mm HEPES, 1 mm EGTA, 0.6 mm MgCl2, 4 mm ATP, 0.3 mm GTP, 12 mm creatine
phosphate, and 50 U/ml phosphocreatine kinase. The pipette resistance was between 2 and 4 MU. Standard extracellular solution
contained the following (in mM): 140 NaCl, 2.4 KCl, 10 HEPES, 10 glucose, 4MgCl2, and 2CaCl2 (pH 7.3, 305mOsm). All experiments
were performed at room temperature (22–23C). Whole-cell recordings were performed on cortical neurons from control and mutant
groups in parallel on the same day (day 13–16 in vitro). All experiments were performed by two independent investigators blinded to
the genotypes. Electrophysiology data were analyzed offline with AxoGraph X software (AxoGraph Scientific).
For current-clamp experiments, the intrinsic electrophysiological properties of neurons were tested by injecting 500-ms square
current pulses incrementing in 20 pA steps, starting at 100 pA. Resting membrane potential (Vm) was calculated from a 50 ms
average before current injection. The membrane time constant (Tau, t) was calculated from an exponential fit of current stimulus
offset. Input resistance (RIn) was calculated from the steady state of the voltage responses to the hyperpolarizing current steps. Mem-
brane capacitance (Cm) was calculated by dividing the time constant by the input resistance. Action potentials (APs) were evoked
with 0.5 s, 20 pA depolarizing current steps. AP threshold was defined as the membrane potential at the inflection point of the rising
phase of the AP. AP amplitude was defined as the difference in membrane potential between the AP peak and threshold, and the
afterhyperpolarization was the difference between the AP threshold and the lowest Vm value within 50 ms. The AP half-width was
defined as the width of the AP at half-maximal amplitude. The maximum depolarization and repolarization rates were determined
by differentiating the AP waveform and finding the peak values. To obtain the neuron’s maximum firing frequency, depolarizing cur-
rents in 20-pA steps were injected until the number of APs per stimulus reached a plateau phase. Rheobase was defined as the min-
imum current required to evoke an AP during the 500ms of sustained somatic current injections. AP half-width adaptation was deter-
mined by dividing the half-width of the last AP of a train at steady state frequency by the first. AP frequency adaptation was
determined by dividing the mean interspike interval of the last four APs by the minimum. The membrane potential values were not
corrected for the liquid junction potential. GABAergic neurons were classified as fast spiking (FS) if their maximum mean firing
rate reached above 60 Hz and their AP half-widths increased by less than 25% during the AP train (Casale et al., 2015; Avermann
et al., 2012). All others were considered non-fast spiking (NFS).
For voltage-clamp experiments to measure synaptic currents, two neurons were patched simultaneously and held at 70 mV,
except for evoked IPSC measurements, for which postsynaptic neurons were held at 0 mV. PSCs were triggered by a 2 ms somatic
depolarization to 0mV. The shape of the evoked response, the reversal potential and the effect of receptor antagonists [10 mMNBQX
(Tocris, 1044) or 20 mM bicuculline (BIC, Hello Bio, HB0893)] were analyzed to verify the glutamatergic or GABAergic identities of the
currents. Neurons were stimulated at 0.1 Hz in standard external solution to measure basal-evoked synaptic responses. Sponta-
neous synaptic potentials were recorded in control solution with either NBQX or bicuculline to isolate EPSCs or IPSCs, respectively.
Data were filtered at 1 kHz and analyzed using template-basedminiature event detection algorithms implemented in the AxoGraph X.
The threshold for detection was set at three times the baseline SD from a template of 0.5 ms rise time and 3 ms decay. The E/I ratio
was calculated as the product of the sEPSC frequency and charge over the sum of the sEPSC frequency and charge and the product
of the sIPSC frequency and charge.
KNa Current Measurements
For voltage-clamp experiments to measure the sodium-activated K+ current, neurons were held at 70 mV and given 1 s voltage
pulses in 10 mV steps over a range of 80 to +50 mV. Recordings were obtained for each cell in standard extracellular solution
or extracellular solution containing 0.5 mM Tetrodotoxin (TTX, Abcam, ab120055). To minimize rundown, experiments were started
only after test pulses produced stable delayed outward currents. After steps in standard solution, TTX was applied directly on the
recorded neuron with a custom-built fast flow perfusion system capable of complete solution exchange in less than 1 s. After
30 40 s in TTX, the step protocol was repeated. Current traces from the TTX solution were then subtracted from the current traces
obtained from the standard solution to obtain the difference current. The difference current over the 100 ms at the end of the voltage
pulse was considered the steady state KNa current. Conductance (G) was calculated by dividing the current at each step by the




driving force for K+. Activation curves were created by normalizing the G values to the maximum for each cell. The resulting curves
were fit with a Boltzmann sigmoid function with the bottom constrained to 0 to obtain the voltage at half max conductance (V50). Un-
constrained fits excluding values at voltage steps below 0 mV to minimize the effect of the TTX-sensitive inward current showed the
same significant left-shifts in FS and NFS Kcnt1m/m GABAergic neurons while glutamatergic neurons were not different. Slope was
not significantly different for any tests.
Multi-electrode Arrays
One to seven days before isolation of cortical neurons, 48-well MEA plates (Axion Biosystems, M768-KAP-48) were coated with
50 mg/mL poly-D-lysine (Sigma-Aldrich, P0899-50MG) in borate buffer, then washed three times with PBS and stored in PBS at
4C until use. Prior to use, PBS was aspirated, and plates were dried in a sterilized hood. Cortices were dissected from the brains
of P0 C57BL/6NJ WT or Kcnt1m/m mice of either sex. Pups were decapitated, weighed, and genotyped. The entire cerebral cortex
was rapidly dissected and cut into small pieces under sterile conditions in cold Hibernate A solution (GIBCO, A1247501). Cortices
from two WT or Kcnt1m/m pups were pooled together. The dissected cortices were then enzymatically digested in 20 U mL-1 Papain
plus DNase (Worthington Biochemical, LK003178 and LK003172) diluted in Hibernate A for 20 min at 37C. Cells were pelleted by
centrifugation at 300RCF for 5 min, and then the digestion was neutralized by aspirating off the supernatant and adding warm Hiber-
nate Amedia. Cells were mechanically dissociated by trituration and counted using a hemocytometer with Trypan blue counterstain.
Cells were pelleted by centrifugation at 300RCF for 5 min and resuspended at a density of 6,000 cells/ml in warm Neurobasal-A
(GIBCO, 10888-022) + 1X B27 supplement (GIBCO, 17504-044) + 1X GlutaMax (GIBCO, 35050-061) + 1% HEPES (GIBCO,
15630-080) + 1% Penicillin/Streptomycin (GIBCO, 15140-122) + 1% FBS (GIBCO, 26140-079) + 5 ug/mL Laminin (Sigma-Aldrich,
L2020). 50,000 cells were plated on a pre-coated 48-well MEA plate in a 40 mL drop. The day after plating (DIV1), 100% of the media
was removed and replaced with warm Neurobasal-A + 1X B27 supplement + 1X GlutaMax + 1% HEPES + 1% Penicillin/Strepto-
mycin (NBA/B27 medium). Glial growth was not chemically suppressed. Cultures were maintained at 37C in 5% CO2. Media was
50% changed every other day with fresh, warm NBA/B27 starting on DIV3, after each recording session.
MEA recordings were conducted on media change days prior to media change starting on DIV5. Plates were equilibrated for 5 min
then recorded for 15 min/day using an Axion Biosystems Maestro 768 channel amplifier (Axion Biosystems) at 37C in a CO2 gas-
controlled chamber with Axion Integrated Studios (AxIS) software v2.4 (Axion Biosystems). Each well of a 48-well plate is comprised
of 16 electrodes on a 4 3 4 grid, with each electrode capturing activity of nearby neurons. A Butterworth band-pass filter (200-
3000 Hz) and an adaptive threshold spike detector set at 7X the standard deviation of the noise was used during recordings. Raw
data and spike list files were collected. Spike list files were used to extract additional spike, burst, and network features, using a
custom MEA analysis software package for interpretation of neuronal activity patterns, meaRtools, based on rigorous permutation
statistics that enables enhanced identification of over 70 activity features (Gelfman et al., 2018). Specifically, we analyzed spiking and
bursting rates, burst duration, and the time between bursts (i.e., interburst interval, IBI), as well as synchronicity of the network. We
determined the parameters for detecting neuronal bursts and network events based on published reports and experimentation (Mack
et al., 2014; McConnell et al., 2012). Activity data were inspected to remove inactive electrodes and wells. For an electrode to be
considered active, we required that at least five spikes/min were recorded. Wells in which fewer than 4 electrodes were active for
> 50% of the days of recording were considered inactive and removed from analyses. For synchronous network events, at least 5
electrodes (> 25% of the total in a well) were required to participate in a network event for the network event to qualify as a network
spike or burst. Eventswith fewer participating electrodeswere filtered. Bursts were detected using themaximum interval burst detec-
tion algorithm (NeuroExplorer software, Nex Technologies) implemented in the meaRtools package. We required that a burst consist
of at least 5 spikes and last at least 0.05 s, and that themaximum duration between two spikes within a burst be 0.1 s at the beginning
of a burst and 0.25 s at the end of a burst. Adjacent bursts were further merged if the duration between them was less than 0.8 s.
These parameters were chosen based on literature and on in-house experimentation (Mack et al., 2014). To analyze data over
time, we performed permutedMann-Whitney U tests. The values for each well for the chosen DIVs were combined and aMann-Whit-
ney U (MWU) test was performed. The labels for each well (WT versus Kcnt1m/m) were then shuffled and permuted 1,000 times to
create 1,000 datasets that were tested for significance using an MWU test. We report the permuted p values as the rank of the
true p value within the distribution of permuted p values. We also report the combined p value of the plates, calculated using an
R script developed in-house.
Slice Electrophysiology
P20–29male and femalemicewere deeply anesthetizedwith isoflurane and decapitated. The brain was removed and 350 mmcoronal
slices of frontal cerebral cortex were cut in ice-cold cutting solution (126 mM NaCl, 25 mM NaHCO3, 10 mM d-glucose, 3.5 mM KCl,
1.5 mM NaH2PO4, 0.5 mM CaCl2, 10.0 mM MgCl2) with a Leica VT1000S. Slices were then transferred to a storage chamber with
fresh artificial cerebrospinal fluid (aCSF) containing 126 mM NaCl, 3.5 mM KCl, 1.0 mM MgCl2, 2.0 mM CaCl2, 1.5 mM NaH2PO4,
25 mM NaHCO3, and 10 mM d-glucose, pH 7.3-7.4, and were incubated at 37
C for 30 min. The slices were then incubated at
room temperature for at least another 30 min before recording. All solutions were continuously bubbled with 95% O2 and 5% CO2.
Whole-cell current-clamp and recordings were obtained from cortical layer 2/3 pyramidal cells and interneurons at 32C using a
Multiclamp 700B and Clampex 10.5 software (Molecular Devices). Individual slices were transferred to a recording chamber located
on an upright microscope (BX51; Olympus) and were perfused with oxygenated aCSF (2 mL/min). Neurons were visualized using IR-




differential interference contrast microscopy. Layer 2/3 pyramidal cells were distinguished from interneurons by their triangular
morphology, large soma, and pronounced apical dendrite. NFS GABAergic cells were distinguished from pyramidal neurons by their
typical ovoid-shaped cell bodies and were finally confirmed by electrophysiological recordings as displaying shorter AP half-widths
and higher peak AP frequency (Avermann et al., 2012). Intracellular solution contained (in mM): 136 mM K-gluconate, 17.8 mM
HEPES, 1 mM EGTA, 0.6 mM MgCl2, 4 mM ATP, 0.3 mM GTP, 12 mM creatine phosphate, and 50 U/ml phosphocreatine kinase,
pH 7.2. When patch electrodes were filled with intracellular solution, their resistance ranged from 4–6 MU. Access resistance was
monitored continuously for each cell. The protocols and determination of electrophysiological parameters were conducted as
described above for the culture recordings. All experiments were performed and analyzed by an investigator blinded to the animal
genotypes.
QUANTIFICATION AND STATISTICAL ANALYSIS
Prism 7 (GraphPad Prism, RRID:SCR_002798) was used to perform statistical tests on adult behavioral tests and to create all graphs.
Multiple group comparisons were done using two-tailed t test with correction using the Holm-Sidakmethod,Mann-Whitney U test, or
two-way repeated-measures ANOVA with correction using the Sidak’s test, as indicated. Statistics for MEA data and seizure fre-
quency were performed in R using a Mann-Whitney U test with 1,000 permutations.
To test for statistical significance for all whole cell electrophysiology experiments, we used generalized linear mixed models
(GLMM) in SPSS (26.0 Chicago, III (IBM, RRID:SCR_002865), which allows for within-subject correlations and the specification of
the most appropriate distribution for the data. Because neurons and animals from the same culture or animal are not independent
measurements, culture or litter was used as the subject variable, and animals and neurons were considered within-subject measure-
ments. All data distributions were assessed with the Shapiro-Wilk test. Datasets that were significantly different from the normal dis-
tribution (p < 0.05) were fit with models using the gamma distribution and a log link function, except for synaptic connection prob-
ability, which was fit with the binomial distribution and probit link. Normal datasets were fit with models using a linear distribution and
identity link. We used the model-based estimator for the covariance matrix and goodness of fit was determined using the corrected
quasi likelihood under independencemodel criterion and by the visual assessment of residuals. All values reported in the text, figures,
and tables are estimated marginal means ± standard error.
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Figure S1 
 
Figure S1. Behavioral phenotypes in Kcnt1m/m mice. (A) Line graphs show results from the Open Field 
test, including distance traveled, vertical exploration, and center time, in 10 min increments for 60 min. 
***p<0.001; Two-way repeated measures ANOVA. (B) For the Elevated Plus Maze test, the percent of 
time spent in open arms, closed arms, or at the junction (left), as well as the total number of entries in 
the arms (right), is shown. Unpaired two-tailed t-test with Holm-Sidak correction. (C) For the Fear 
Conditioning test, freezing behavior was measured to assess cued and contextual memory. **p<0.01; 
Mann-Whitney U test. (D) For the Acoustic Startle Response test, startle responses (maximal amplitude) 
were measured across increasing sound bursts (dB). Two-way repeated measures ANOVA. (E) For the 
Nesting Behavior tests, the nest quality (left; nesting score) and weight of remaining intact nesting 
material (right) are shown. n = 8 WT female, 10 WT males, 13 Kcnt1m/m females, and 11 Kcnt1m/m males. 
*p<0.05; ***p<0.001; Unpaired two-tailed t-test with Holm-Sidak correction. n.s., not significant. 




Figure S2. Cortical areas mapped using the Allen Mouse Brain Common Coordinate Framework (CCF). 
Map areas numbered in red were imaged, at least partially, in all sessions by widefield calcium imaging. 
Alignment of the activity maps from Kcnt1m/ m-G6s mice to the Allen Mouse CCF showed that the 
interictal epileptiform discharges localized primarily to the secondary motor cortex region (area 1), 












Figure S3. KCNT1 expression in glutamatergic and GABAergic neurons from mouse and human cortex.  
(A) RNA-seq data from the Allen Cell Types Database for mouse cortex (https://portal.brain-
map.org/atlases-and-data/rnaseq/mouse-whole-cortex-and-hippocampus-smart-seq). The heat map 
shows the median Kcnt1 transcript levels (top row) for all GABAergic neuron clusters and excitatory 
pyramidal cell clusters in layer 2/3. Each vertical bar represents a cluster. Below are markers for 
GABAergic (Gad1) and glutamatergic (Vglut1) neurons, as well as markers for subpopulations of 
GABAergic neurons showing relatively high expression of Kcnt1 in Sst and Pvalb-expressing neurons. 
(B) RNA-seq data from the Allen Cell Types Database for human cortex (https://portal.brain-
map.org/atlases-and-data/rnaseq/human-multiple-cortical-areas-smart-seq). The heat map shows the 
trimmed mean KCNT1 transcript levels (top row) for all GABAergic neuron clusters and all excitatory 
pyramidal cell clusters that contain layer 2/3 neurons. Each vertical bar represents a cluster. Below are 
markers for GABAergic (GAD1) and glutamatergic (VGLUT1) neurons, as well as markers for 
subpopulations of GABAergic neurons showing relatively high expression of KCNT1 in SST and PVALB-




Figure S4. The changes in Kcnt1m/m NFS neuron KNa currents are not due to alterations in neuron size. 
(A and B) Current-voltage plots of the membrane current (mean ± SEM) normalized to the capacitance 
recorded in control (blue), and 0.5 µM TTX (green) -containing, extracellular solution from WT (A) and 
Kcnt1m/m NFS (B) neurons. The difference current (yellow) was calculated by subtracting the membrane 
current in TTX from the response in control external solution for each neuron. (C) Comparison of the 
TTX-sensitive current density (mean ± SEM) for each voltage step from -80 to 50 mV in WT and Kcnt1m/m 
NFS neurons. (D) Comparison of the TTX-sensitive current density (mean ± SEM) for each voltage step 
from -80 to 0 mV in WT and Kcnt1m/m NFS neurons to illustrate the values that are too small to be seen 
on the plot in panel C. Statistical significance for I-V plots was tested using Generalized Linear Mixed 
Models with genotype and current step as fixed effects, followed by pairwise comparisons at each level. 







































Figure S5. Heterozygous expression of the Y777H variant causes intermediate effects on KNa currents 
in all neuron types, but increases rheobase only in NFS GABAergic neurons. (A) Current-voltage plot of 
KNa current recorded in WT, Kcnt1m/+, and Kcnt1m/m glutamatergic neurons. (B) Individual values and 
mean ± SEM for the rheobase current in WT, Kcnt1m/+, and Kcnt1m/m glutamatergic neurons. (C) Current-
voltage plot of KNa current recorded in WT, Kcnt1m/+, and Kcnt1m/m FS GABAergic neurons. (D) Individual 
values and mean ± SEM for rheobase current in WT, Kcnt1m/+, and Kcnt1m/m FS GABAergic neurons. (E) 
Current-voltage plot of KNa current recorded in WT, Kcnt1m/+, and Kcnt1m/m NFS GABAergic neurons. (F) 
Individual values and mean ± SEM for rheobase current in WT, Kcnt1m/+, and Kcnt1m/m NFS GABAergic 
neurons. Related to Figure 5. 
Figure S6 
Figure S6. Spontaneous EPSCs are increased onto Kcnt1m/m excitatory and NFS neurons, but not FS 
neurons. Example traces of sEPSCs recorded in WT (black) and Kcnt1m/m(colors) neurons of the indicated 
subtypes. The bar graph on the right shows the mean frequencies ± SEM. Significance values are labeled 

























Table S1  
 
  Number of GTCS or TS Sleep Analysis 







1 25 0 23 2 677.8 693.3 49.65 
2 0 0 0 0 711.3 666.5 50.3 
3 11 0 9 2 776.1 598.6 64.8 
4 19 0 19 0 798.9 601.1 30.5 
5 12 2 7 3 681.9 671.6 86.6 
6 46 1 45 0 655.55 747.55 27.55 
7 32 3 28 1 616 765.65 45.95 
 
Table S1. Seizures in Kcnt1 mutant mice predominately happen during NREM sleep. Shown are the 
numbers of GTCS or TS events in wake, NREM sleep, and REM sleep in 7 Kcnt1 homozygous mutant 
mice. Note the majority of seizure events occurred during NREM sleep. EEG and EMG were recorded for 
1-3 days. The amount of wake, NREM sleep, and REM sleep time were normalized to a 24-h period. 

























Table S2. Electrophysiological parameters of current clamp recordings from neuronal cultures. For an 
explanation of the parameters, see Methods (thresh. = threshold, amp. = amplitude, h.w. = half-width, 
depol. = depolarization, repol. = repolarization, AHP = afterhyperpolarization, I50 = current injection 
needed to achieve half-maximal AP rate, n.d. = not determined). Values shown are estimated marginal 
means ± the standard error as determined by implementing a Generalized Linear Mixed Model. P-values 
< 0.05 are in bold type. The n values are the number of neurons obtained from 16 mice (8 WT, 8 






 Glutamatergic                Fast Spiking GABA                 Non-Fast Spiking GABA 
WT Kcnt1m/m                                 WT Kcnt1m/m                                 WT Kcnt1m/m                                 
n = 33 n = 34 p n = 29 n = 31 p n = 34 n = 31 p 
Vrest (mV) -56.7±1.4 -59.8±1.5 0.07 -50.7±1.5 -52.1±1.5 0.46 -51.0±1.6 -52.0±1.6 0.62 
Rin (MΩ) 155±12 187±16 0.09 91±8 84±7 0.43 184±14 127±10 0.001 
Tau (ms) 38.6±3.7 39.6±3.7 0.83 15.7±1.5 15.5±1.5 0.96 25.0±2.4 20.9±2.1 0.15  
Cm (pF) 243±14 230±13 0.42 172±10 190±11 0.14 146±8 171±10 0.026 
AP thresh. 
(mV)  
-28.0±1.1 28.4±1.2 0.82 -24.8±1.2 -27.1±1.2 0.13 -26.9±1.3 -25.7±1.3 0.49 
AP amp. 
(mV) 
76.8±1.4 73.2±1.5 0.09 68.8±1.4 71.6±1.4 0.15 66.8±1.4 67.7±1.5 0.66 
AP h.w. 
(ms) 
2.18±0.12 2.40±0.14 0.09 0.89±0.05 0.91±0.05 0.80 1.19±0.06 0.99±0.05 0.001 
Depol. rate 
(mV/ms) 
169±10 173±10 0.75 223±14 243±15 0.22 177±11 185±12 0.50 
Repol. rate 
(mV/ms) 
32.5±2.0 32.6±2.0 0.95 88.4±5.6 91.3±8.7 0.64 61.9±3.7 75.1±4.7 0.005 
Rheobase 
(pA) 
151±29 142±31 0.81 364±29 464±28 0.007 189±27 350±29 0.00014 
AHP (mV) 12.1±0.5 12.2±0.7 0.92 26.0±0.8 26.6±0.9 0.34 21.2±0.5 24.7±1.9 0.025 
f-I slope 
(Hz/nA) 
40±6 40±6 0.97 30±3 26±3 0.34 24±3 12±2 0.004 
I50 (pA) 133 ± 9 121 ± 11 0.44 646 ± 24 737 ± 28 0.017 231 ± 45 354 ± 23 0.007 
H.w. adap. n.d n.d  1.11±0.01 1.10±0.02 0.55 1.53±0.06 1.47±0.08 0.23  
AP rate 
(Hz) 
26.3±3.6 23.2±3.1 0.21 78.9±4.2 80.6±8.8 0.71 36.0±4.7 34.4±4.6 0.63 
Frequency 
adaptation 













Table S3. Synaptic current data from neuronal cultures. For an explanation of the parameters, see 
Methods (freq. = frequency, amp. = amplitude, E/I = excitation inhibition). Values shown are estimated 
marginal means ± the standard error as determined by implementing a Generalized Linear Mixed Model. 
P-values < 0.05 are in bold type. The n values are the number of neurons obtained from 4 litters and 8 
mice (4 WT, 4 Kcnt1m/m). GABAergic neurons were not subclassified for sIPSC measurements because the 



















 Excitatory neurons               Inhibitory neurons 
WT Kcnt1m/m                     WT Kcnt1m/m                     
n = 56 n = 57 p n = 37 n = 45 p 
sEPSC freq. 
(Hz) 
3.0±0.86 5.6±0.76 0.001 10.4±2.0 11.4±2.0 0.93 
sEPSC 
amp. (pA) 
17.6±1.2 20.1±1.4 0.16 30.8±2.2 32.2±2.0 0.60 
sEPSC 
decay (ms) 
3.5±0.07 3.5±0.07 0.83 2.7±0.08 2.9±0.09 0.19 
 n = 28 n = 25  n = 21 n = 26  
sIPSC freq. 
(Hz) 
2.1±0.3 2.7±0.4 0.09 2.6±0.4 2.9±0.4 0.20 
sIPSC amp. 
(pA) 
27.4±2.3 32.5±2.5 0.17 25.8±2.5 27.6±2.4 0.63 
sIPSC 
decay (ms) 
18.4±1.3 19.5±1.3 0.17 16.5±1.4 17.0±1.3 0.57 
E/I ratio 0.34±0.05 0.45±0.06 0.037 0.74±0.09 0.66±0.08 0.36 
Table S4 
 
 Glutamatergic                Non-Fast Spiking GABA 
WT Kcnt1m/m                     WT Kcnt1m/m                     
n = 13 n = 12 p n = 14 n = 13 p 
Vrest (mV) -65.5±2.4 -63.7±2.4 0.60 -60.9±2.2 -65.5±2.4 0.16 
Rin (MΩ) 124±26 106±24 0.38 299±59 161±37 0.013 
Tau (ms) 21.3±2.3 14.3±2.4 0.04 18.6±2.3 14.5±2.3 0.20 
Cm (pF) 163.9±28 133.6±24 0.28 66.1±11 105.8±19 0.032 
AP thresh. (mV) -32.6±1.8 -25±1.9 0.006 -32.1±1.6 -31.5±1.9 0.82 
AP amp. (mV) 77.5±4.1 74.2±4.6 0.59 65.3±4.3 75.2±5.1 0.08 
AP h.w. (ms) 2.29±0.14 2.52±0.16 0.30 1.26±0.07 1.33±0.08 0.49 
Rheobase (pA) 158.5±23 206.7±24 0.16 94±22 228±23 0.003 
AHP (mV) 7.2±1.3 7.4±1.2 0.91 9.8±1.2 8.8±1.4 0.57 
f-I slope (Hz/nA) 24±5 18±3 0.35 67±14 25±6 0.023 
I50 (pA) 149 ± 32 180 ± 39 0.54 136 ± 9  294 ± 20 0.001 
H.w. adaptation 1.69±0.08 1.64±0.08 0.64 1.33±0.08 1.33±0.08 0.98 
AP rate 22.9±2.5 22.3±2.6 0.87 37.1±2.5 35.2±2.9 0.63  
Freq. adaptation 1.71±0.42 1.84±0.77 0.88 3.64±0.56 4.41±0.77 0.15 
 
Table S4. Electrophysiological parameters of current clamp recordings from acute slices. For an 
explanation of the parameters, see Methods (thresh. = threshold, amp. = amplitude, h.w. = half-width, 
I50 = current injection needed to achieve half-maximal AP rate). Values shown are estimated marginal 
means ± the standard error as determined by implementing a Generalized Linear Mixed Model. P-values 
< 0.05 are in bold type. The n values are the number of neurons obtained from 16 mice (9 WT, 7 
Kcnt1m/m) from 8 litters. Related to Figure 7. 
 
 
 
 
 
 
 
 
 
 
 
